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ABSTRACT 
Social stress is a prevalent factor in society that can cause or exacerbate neuropsychiatric 
disorders including depression and posttraumatic stress disorder.  According to the National 
Institutes of Health, 6.9% of adults in this country currently suffer from depression, and 4.1% 
suffer from an anxiety disorder.  Unfortunately, current treatments are ineffective in reducing or 
alleviating symptoms in a majority of these patients. Thus, it is critical to understand how social 
stress changes in brain and behavior so that we might develop alternative treatments. Brain 
derived neurotrophic factor (BDNF), which binds to tyrosine kinase B (TrkB) receptors, plays a 
role in fear learning and in behavioral responses to stress, although we do not currently know 
whether BDNF promotes or prevents these responses. The purpose of this project was to 
understand how BDNF alters brain and behavior in response to social stress using a model of 
social stress in Syrian hamsters, termed conditioned defeat (CD). CD refers to the marked 
increase in submissive and defensive behavior following social defeat. Specific Aim (SA) 1 tested 
the hypothesis that BDNF, via TrkB receptors, promotes CD learning. Instead, we found that 
BDNF and a selective TrkB receptor agonist reduced CD and that a TrkB receptor antagonist 
enhanced CD. SA 2 tested the hypothesis that the behavioral response observed following 
systemic administration of TrkB-active drugs is mediated via their action in specific nodes of the 
neural circuit underlying CD. Unfortunately, the vehicle in which these drugs are dissolved 
independently activates immediate early gene expression making interpretation of these data 
impossible. Finally, SA 3 tested the hypothesis that BDNF alters defeat-induced neural 
activation at least in part by acting in the medial prefrontal cortex (mPFC). We demonstrated 
that BNDF microinjected into the mPFC site-specifically altered defeat-induced neural 
activation in the CD neural circuit supporting this hypothesis. Overall, these data suggest that 
BDNF acts to prevent social stress-induced changes in behavior, at least in part via the 
basolateral amygdala and the mPFC, and that BDNF-active drugs might be a useful avenue to 
pursue to discover new treatments for patients that suffer from stress-related neuropsychiatric 
disorders. 
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1 GENERAL INTRODUCTION  
Social stress is the most common source of stress experienced by humans in modern 
society (Bjorkqvist, 2001). Given the frequency with which humans interact with one another at 
work, in school or at home (Agid et al., 2000; Kelleher et al., 2008), it is not surprising that 
social stress is so prevalent.  Stress, in general, is usually defined as a challenge or a perturbation 
that disturbs homeostasis. Stressors, including social stress, activate the hypothalamic pituitary 
adrenal (HPA) axis and the autonomic nervous system (ANS), the 2 main stress response 
systems of the body. Activation of these 2 systems, in turn, increases the release of cortisol and 
catecholamines (Dickerson and Kemeny, 2004; Kirschbaum et al., 2004). Increases in these 
neurochemicals, particularly if sustained, can have numerous detrimental effects on the health 
of an individual. Stress suppresses the immune system thereby increasing an individual’s 
susceptibility to illness (Segerstrom and Miller, 2004). Stressed individuals are also more likely 
to experience changes in weight (Block et al., 2009), increases in blood pressure (Ghiadoni et al., 
2000), and an increased risk of arteriosclerosis, hypertension, and other metabolic disorders 
(Chrousos, 2009). Furthermore, exposure to stress reduces telomere length (Epel et al., 2004), 
which is related to early onset of age-related diseases and which may explain in part why 
stressed individuals are at a higher risk of disrupted homeostasis, health problems, and 
decreased quality of life (Russ et al., 2012).   
Stress unfortunately is also thought to be a critical factor that places individuals at an 
increased risk for developing neuropsychiatric disorders (Sapolsky, 2000; Karatsoreos & 
McEwen, 2011) including depression, posttraumatic stress disorder (PTSD), and other anxiety 
disorders (Gilbert & Allan 1998; Heim & Nemeroff 2001; McEwen & Stellar 1993; Pêgo et al., 
2010; Shin & Liberzon, 2010). According to 12-month prevalence data from the National 
Institutes of Mental Health, 6.9 percent of adults in this country suffer from depression, and 
4.1% of the adult population suffers from an anxiety disorder such as PTSD (NIH, NIH). 
Furthermore, the World Health Organization reports that depression is the third most 
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important cause of disease burden worldwide (WHO). Even more troubling is the fact that many 
individuals with disorders such as depression do not experience relief from their symptoms after 
taking many of the currently recommended treatments (Trivedi et al., 2006a; Trivedi et al., 
2006b). To date, there is no treatment that is completely effective, and the emotional and 
economic burden is mounting (Kalia, 2002; Hoffman et al., 2008). Thus, it is critical that we 
improve our understanding of the mechanisms whereby stressors, such as social stress, lead to 
changes in brain and behavior so that we might discover alternative treatment options for 
individuals suffering from stress-related mental illness.  
Recent research has suggested that brain derived neurotrophic factor (BDNF) systems 
may present a novel treatment option for depressed individuals. BDNF is a neurotrophic protein 
found in the brain and periphery. BDNF is secreted by neurons and binds primarily to tyrosine 
kinase B receptors (TrkB) (Chao et al., 2006; Huang and Reichardt, 2003; Reichardt, 2006), 
which are found on neurons and glia cells (Zhou et al., 1998; Zhou et al., 1993). BDNF promotes 
neuronal growth, survival, plasticity, learning and memory, and neuronal development 
(reviewed in Yoshii and Constantine-Paton, 2010;Chao et al., 2006; Minichiello, 2009). 
Importantly, BDNF is often suppressed following exposure to stress in humans, and reduced 
BDNF protein in serum is observed in patients with numerous psychiatric illnesses, including 
major depressive disorder (Karege et al., 2002; reviewed by Duman and Monteggia, 2006; 
Castren & Rantamaki, 2010), PTSD (Dell’osso et al., 2009; review by Rakofsky et al., 2012; 
Suliman, Hemmings, & Seedat, 2013) as well as in blood platelets of suicidal patients (reviewed 
in Dwivedi, 2010). 
Supporting the potential therapeutic effect of BDNF in depression, numerous labs using 
animal models have reported that BDNF is increased following antidepressant treatment 
(Karege et al., 2002; reviewed by Duman and Monteggia, 2006; Castren & Rantamaki, 2010; 
Suliman, Hemmings, Seedat, 2013). Furthermore, blocking BDNF receptor activation in the 
prefrontal cortex prevents antidepressant effects in mice as measured in the forced swim test 
17 
(Saarelinen et al., 2003). Although these data are intriguing and encouraging, additional 
research is needed to explore how BDNF changes following social stress and whether 
manipulations that alter BDNF neurotransmission are effective in changing behavioral 
responses to social stress.  
Animal models provide a non-human alternative to discover the mechanisms whereby 
exposure to social conflict leads to adverse physical and psychological outcomes (Bartolomucci 
2007). One of the most prevalent animal models used to study social conflict is the resident-
intruder model. This model involves social conflict between conspecifics that compete for a 
desired resource such as a territory or a mate (reviewed by Tamashiro et al., 2005; Blanchard, 
McKittrick, and Blanchard, 2001; Koolhass et al.,2013). Resident-intruder models have been 
developed in numerous species including mice, rats, hamsters, and non-human primates and 
have been shown to produce depression-like and anxiety-like changes in behavior much like 
those observed in humans following exposure to social stress (reviewed by Tamashiro et al., 
2005). The overarching purpose of the current project is to use an animal model of social 
conflict to gain a better understanding of the role BDNF plays in brain and behavioral responses 
to social stress. 
Our lab studies a unique model of social stress in Syrian hamsters, which are naturally 
solitary and are highly territorial. Thus, unlike some other species (e.g., rats) used in resident-
intruder models, complex social housing arrangements are not required to induce aggression in 
hamsters. In addition, both male and female Syrian hamsters spontaneously exhibit aggressive 
behavior towards conspecific intruders (Huhman et al., 2003) making them ideal subjects for 
the study of social conflict.  Additionally, their agonistic behavior is highly ritualized and few 
injuries occur as a result. In spite of these natural aggressive tendencies, after a brief social 
defeat hamsters no longer defend their home cage or territory, even against a smaller, non-
aggressive intruder (NAI). Instead of attacking the NAI, a previously defeated hamster 
subsequently exhibits no aggression and instead displays submissive and defensive behavior 
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toward the intruder. This dramatic behavioral change following social defeat has been termed 
conditioned defeat (CD) (Potegal et al., 1993). In hamsters, the submissive behavior and the 
absence of aggression that characterizes CD can last at least a month in the majority of subjects 
after brief social defeat (Huhman et al., 2003). Defeated animals also exhibit increased plasma 
adrencorticotropin, beta-endorphin, and cortisol, suggesting that social defeat is a salient 
stressor for these animals (Huhman et al., 1990: Huhman et al., 1991a; Huhman et al., 1991b; 
Huhman et al., 1992).  
Beyond the hormonal and behavioral impacts of social defeat, our lab has examined the 
involvement of numerous neurochemical signals and brain nuclei in CD. Neurochemicals 
including serotonin (5HT), cAMP response element-binding protein (CREB), gamma-amino 
butyric acid (GABA), dopamine (DA), corticotropin-releasing hormone (CRH), glutamate, and 
BDNF have all been examined to gain a better understanding of the mechanisms underlying 
social stress-induced behavioral change in hamsters (Cooper & Huhman 2005; Cooper & 
Huhman 2007; Day et al., 2011; Jasnow & Huhman, 2001; McDonald et al., 2012). Over the past 
several years our lab has also worked to identify a putative neural circuit that underlies CD 
(Markham & Huhman, 2008; Markham et al., 2009; Markham et al., 2010; McDonald et al., 
2012). As depicted in the circuit diagram (Figure 1), several nuclei are involved in the acquisition 
and/or expression of CD. The basolateral amygdala (BLA), in particular, seems to play a central 
role in this circuit as the BLA is necessary for both the acquisition and expression of CD 
(Jasnow, 2005; Markham et al., 2010; Day et al., 2011), and synaptic plasticity in the BLA is 
required for CD learning to occur (Jasnow, 2005; Markham et al., 2010).  Other brain areas 
such as the medial prefrontal cortex (mPFC) appear to be necessary only for the acquisition of 
CD (Markham et al., 2012). [Note: the mPFC is composed of the infralimbic cortex (IL) and 
prelimbic cortex (PL) in rodents and is analogous to area Brodmann’s Areas (BA) 25 and 32 
respectively in humans (Milad et al., 2007; Myers-Schulz & Koenigs, 2012; Quirk & Beer, 2006; 
Slattery, Neumann, & Cryan, 2011).]. Interestingly, the projections between the amygdala and 
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the mPFC are thought to play a role in neuropsychiatric illnesses such as PTSD and depression. 
For example, decreased activity of the PFC in disease states such as PTSD (Rabinak et al., 2014; 
Jovanovic et al., 2013) and depression (Rive et al., 2013; Erk et al., 2010) may fail to inhibit or 
even cause an over-active amygdala (Hamilton et al., 2008) in humans. 
Current findings regarding changes in BDNF following social stress are somewhat 
inconsistent. For example, BDNF protein expression is increased in the mPFC by repeated social 
stress in mice (Nikulina et al., 2012) and in the amygdala following chronic stress (reviewed by 
Boyle, 2013). Others, however, report that social stress decreases BDNF protein in the 
amygdala, the hypothalamus, and the hippocampus (Fanous et al., 2010; Pizarro et al., 2004). 
Still other experiments indicate that BDNF mRNA is reduced 24 h after social defeat stress in 
the hippocampus, BLA, and parts of the cortex in mice (Pizarro et al., 2004), but we have shown 
that a brief social defeat increases BDNF mRNA in the BLA as compared to controls (Taylor et 
al., 2011).  Thus, the current data are inconclusive as to the response of BDNF mRNA and 
protein to various stressors and to the role that BDNF plays in behavioral responses to stress.  
Some data indicate that BDNF may promote behavioral changes following stress, while other 
findings indicate that BDNF may protect against deleterious effects of stress and may thus act as 
a sort of antidepressant.  It is possible that BDNF is altered by social stress in a site-specific 
manner (reviewed in Sakata, 2013) and that peripheral assays of BDNF, as reported in humans, 
are representative of a net effect of complex regional changes.   
Our finding that social defeat stress increases BDNF mRNA in the amygdala suggests 
that BDNF might act in the amygdala to promote subordinate behavioral responses to social 
defeat in hamsters. To determine if inhibiting BDNF signaling would reduce the acquisition of 
CD and restore territorial aggression, Taylor and colleagues injected a non-specific Trk receptor 
antagonist, k252a, directly into the BLA (Taylor et al., 2011). K252a administered site-
specifically in the BLA before defeat reduced the display of submission towards an NAI 24 h 
after defeat, indirectly supporting the hypothesis that BDNF promotes CD learning (Taylor et 
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al., 2011). However, site-specific injections cannot be used in humans, thus it is also important 
to determine if systemic injections that target the BDNF system are also effective in altering 
social stress-induced behavioral changes observed in socially defeated hamsters. Since the 
completion of our earlier study using k252a, novel compounds have been developed that 
specifically target TrkB receptors (Cazorla et al., 2011; Jang et al., 2010).  These drugs offer a 
much improved way to test specifically the role of BDNF and TrkB receptors than does k252a, 
which is a non-specific Trk receptor antagonist that binds to both TrkA and TrkB receptors, as 
well as to a wide variety of other kinases (Arthur et al., 2005; Berg et al., 1992; Koizumi et al., 
1988; Sofroniew et al., 2001). These novel TrkB compounds also allow us to examine the effect 
of peripherally administered BDNF-active compounds on social stress-induced behavioral 
changes and to determine if these compounds promote or prevent these changes in hamsters.  
Although these peripheral injections do not promote our understanding of the neural circuitry 
underlying the drugs’ effects, the peripheral route of administration has potential translational 
implications for the utility of these drugs to alter responses to social stress. Based on our earlier 
findings, we expected that the peripheral administration of a specific TrkB receptor agonist 
would promote CD and that a specific TrkB receptor antagonist would decrease CD. This 
prediction will be tested in Specific Aim 1 of the current project. 
Beyond the potential behavioral effect that these novel compounds may have when given 
peripherally in hamsters, it is also important to determine where in the brain these drugs are 
acting. Understanding where peripheral compounds are acting in the brain will 1) direct future 
studies for investigating the role of BDNF within specific nuclei, and 2) identify how changes in 
BDNF may alter neuronal activity in a nucleus dependent manner within the putative CD circuit. 
The purpose of Aim 2 is to determine in which brain nuclei a peripherally administered TrkB 
receptor agonist might act to alter neuronal activation following a defeat experience. FOS is the 
protein product of c-fos, an immediate early gene that is transiently activated in response to a 
cellular stimuli and has been used as a proxy to examine neuronal activation. In Aim 2, we 
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measured neuronal activation using FOS immunohistochemistry (FOS-IR). Specifically, we 
administered a TrkB agonist immediately following social defeat and examined FOS-IR 60 min 
later in the PL, IL, and the BLA. These 3 nuclei were selected because 1) they are part of the 
putative CD circuit (Figure 1), 2) TrkB receptors are found in these nuclei (Fryer et al., 1996), 3) 
BDNF is reported to play a role in stress responding in these nuclei (reviewed in Duman & 
Monteggia, 2006), and 4) defeat-induced neural activity as measured via FOS is robust in these 
areas (Bourne et al., 2013; Kollack-Walker et al., 1997; Kollack-Walker et al., 1999).  
As mentioned above, the mPFC is necessary for the acquisition of CD (Markham et al., 
2012). The mPFC, specifically area BA 32 in humans, is analogous to the rodent prelimbic 
cortex, whereas area BA 25 is analogous to the infralimbic cortex in rodents (Milad et al., 2007; 
Myers-Schulz & Koenigs, 2012; Quirk & Beer, 2006; Slattery, Neumann, & Cryan, 2011). 
Interestingly, both of these nuclei are active following stress, as measured by immediate early 
genes, such as c-fos. Repeated social defeat, for example, increases delta FOS B in the IL and PL 
(Nikulina et al., 2012), suggesting that both the PL and IL are active following this stressor. 
Studies examining the IL and PL individually have found region-specific differences in neural 
activation. Morrison and colleagues, for example, found that FOS-IR is increased in the IL of 
dominant as compared to subordinate Syrian hamsters (Morrison et al., 2012). When muscimol 
is site-specifically administered in the IL of dominant hamsters, then CD is increased (Morrison 
et al., 2013), suggesting that the IL is important for resistance to defeat stress. Similarly, lesions 
of the IL eliminate the stress-reducing effects of enriched housing environments on social defeat 
in mice (Lehmann and Herkenham, 2011). Labs that have studied both the IL and PL have 
found that stimulation of the IL reduces conditioned fear (Milad, Vidal-Gonzalez, & Quirk, 
2004), whereas stimulation of the PL increases the expression of conditioned fear (Vidal-
Gonzalez et al., 2006). Furthermore, recent work suggests that the PL underlies susceptibility to 
social defeat. Specifically, over expression of delta FOSB in the PL and infusion of a CCK agonist 
into the PL promote depression-like and anxiety-like behaviors after social defeat (Vialou et al., 
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2014). Recent work using BDNF knockout mice has found that BDNF in the PL is necessary for 
the consolidation of fear learning (Choi et al., 2010; Choi et al., 2012), whereas BDNF in the IL is 
necessary for extinction of fear (Peters et al., 2010), thus providing additional evidence that 
these 2 nuclei may act in opposition and that BDNF is involved. Even with the differences in 
neuronal activation in the PL and IL, we still expected to see activation due to stress, and 
therefore we predicted that FOS-IR would increase in the IL and the PL following social defeat in 
Syrian hamsters.  It was also possible, however, that activation was higher in the PL given that it 
is appears to be involved in stress susceptibility. Given the role of BDNF in the IL and PL, we 
further predicted that defeat-induced FOS-IR will be enhanced in the PL following the 
peripheral administration of a TrkB receptor agonist. This prediction was tested in Specific Aim 
2 of the current project. 
Given the key role the BLA plays in CD, we also expected to see an increase in FOS-IR 
expression in this nucleus following social defeat, as observed previously (Markham et al., 
2010). We, therefore, predicted that FOS-IR would increase in the BLA following social defeat in 
Syrian hamsters. Furthermore, we tested whether a TrkB receptor agonist enhances this neural 
activation given that BDNF in the BLA appears to play a key role in CD learning following social 
stress. These predictions were tested in Specific Aim 2 of the current project.  
Much attention has been paid to the projections between the amygdala and the mPFC 
and their potential dysregulation in neuropsychiatric illnesses in humans. Interestingly, work in 
animal models has found that reciprocal projections between the amygdala and the mPFC are 
involved in fear learning and in threat identification (Ishikawa & Nakamura, 2003; Marek et al., 
2013; Ongur & Price, 2000). Specifically tract tracing studies have found that the IL and PL 
project to different sub-nuclei within the amygdala (Vertes, 2004; Gabbott, 2005) and that 
stimulation of the PL enhances freezing (Vidal-Gonzalez et al., 2006) whereas stimulation of the 
IL reduces freezing (Milad & Quirk, 2002; Milad et al., 2004). Other data indicate that these 2 
sub-nuclei may act in opposition as the PL is necessary for fear expression, whereas the IL is 
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necessary in fear extinction (Sierra-Mercado et al., 2011). It has previously been suggested that 
the projections from the PL to the basal nucleus of the amygdala are excitatory and, in turn, 
increase stress-induced freezing via projections to the central amygdala (Vidal-Gonzalez et al., 
2006; Sierra-Mercado et al., 2011). In contrast, projections of the IL synapse on the intercalated 
cells, which then inhibit the central amygdala to reduce freezing behavior (Vidal-Gonzalez et al., 
2006; Sierra-Mercado et al., 2011).  
Recent work suggests that BDNF acts in a nucleus dependent manner in the PL and the 
IL to regulate fear learning (Choi et al., 2010; Choi et al., 2012; Peters et al., 2010). Our third 
specific aim was therefore designed to examine the hypothesis that BDNF in the mPFC modifies, 
in a site-specific manner, neural activation in the BLA following social defeat.  Based on the 
aforementioned connections as laid out in Figure 2 (adapted from Vidal-Gonzalez et al., 2006; 
Sierra-Mercado et al., 2011), we expected that BDNF administered into the PL would enhance 
defeat-induced FOS-IR in the BLA and CeA, whereas BDNF administered into the IL would 
suppress defeat-induced FOS-IR in the BLA and CeA.  
In conclusion, it was the goal of this dissertation to test the hypothesis that BDNF, via its 
action at TrkB receptors, enhances the effects of social stress and that it does so, at least in part, 
by binding in the PL, which in turn enhances the response of the BLA to social defeat. This 
hypothesis was addressed by the following specific aims (SAs): 
SA 1:Does peripheral administration of drugs that activate or inhibit TrkB 
receptors have stress-promoting or stress-preventing effects, respectively? 
SA 2:Does peripheral administration of a TrkB receptor agonist in combination 
with social defeat decrease neural activity as measured by FOS in the IL and increase 
FOS in the PL and BLA?   
SA 3:Do microinjections of BDNF into the IL inhibit neural activity in the BLA? 
 
 
24 
 
1.1 References  Adachi	  N,	  Numakawa	  T,	  Richards	  M,	  Nakajima	  S,	  Kunugi	  H.	  2014.	  New	  insight	  in	  expression,	  transport,	  and	  secretion	  of	  brain-­‐derived	  neurotrophic	  factor:	  Implications	  in	  brain-­‐related	  diseases.	  World	  journal	  of	  biological	  chemistry	  5:	  409-­‐28	  Agid	  O,	  Kohn	  Y,	  Lerer	  B.	  2000.	  Environmental	  stress	  and	  psychiatric	  illness.	  Biomedicine	  &	  
pharmacotherapy	  =	  Biomedecine	  &	  pharmacotherapie	  54:	  135-­‐41	  Arthur	  DB,	  Akassoglou	  K,	  Insel	  PA.	  2005.	  P2Y2	  receptor	  activates	  nerve	  growth	  factor/TrkA	  signaling	  to	  enhance	  neuronal	  differentiation.	  Proceedings	  of	  the	  
National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  102:	  19138-­‐43	  Bartolomucci	  A.	  2007.	  Social	  stress,	  immune	  functions	  and	  disease	  in	  rodents.	  Frontiers	  in	  
neuroendocrinology	  28:	  28-­‐49	  Berg	  MM,	  Sternberg	  DW,	  Parada	  LF,	  Chao	  MV.	  1992.	  K-­‐252a	  inhibits	  nerve	  growth	  factor-­‐induced	  trk	  proto-­‐oncogene	  tyrosine	  phosphorylation	  and	  kinase	  activity.	  The	  
Journal	  of	  biological	  chemistry	  267:	  13-­‐6	  Bjorkqvist	  K.	  2001.	  Social	  defeat	  as	  a	  stressor	  in	  humans.	  Physiology	  &	  behavior	  73:	  435-­‐42	  Blanchard	  RJ,	  McKittrick	  CR,	  Blanchard	  DC.	  2001.	  Animal	  models	  of	  social	  stress:	  effects	  on	  behavior	  and	  brain	  neurochemical	  systems.	  Physiology	  &	  behavior	  73:	  261-­‐71	  Block	  JP,	  He	  Y,	  Zaslavsky	  AM,	  Ding	  L,	  Ayanian	  JZ.	  2009.	  Psychosocial	  stress	  and	  change	  in	  weight	  among	  US	  adults.	  American	  journal	  of	  epidemiology	  170:	  181-­‐92	  Bourne	  AR,	  Mohan	  G,	  Stone	  MF,	  Pham	  MQ,	  Schultz	  CR,	  et	  al.	  2013.	  Olfactory	  cues	  increase	  avoidance	  behavior	  and	  induce	  Fos	  expression	  in	  the	  amygdala,	  hippocampus	  and	  prefrontal	  cortex	  of	  socially	  defeated	  mice.	  Behavioural	  brain	  research	  256:	  188-­‐96	  Boyle	  LM.	  2013.	  A	  neuroplasticity	  hypothesis	  of	  chronic	  stress	  in	  the	  basolateral	  amygdala.	  
The	  Yale	  journal	  of	  biology	  and	  medicine	  86:	  117-­‐25	  Castren	  E,	  Rantamaki	  T.	  2010a.	  The	  role	  of	  BDNF	  and	  its	  receptors	  in	  depression	  and	  antidepressant	  drug	  action:	  Reactivation	  of	  developmental	  plasticity.	  Developmental	  
neurobiology	  70:	  289-­‐97	  Castren	  E,	  Rantamaki	  T.	  2010b.	  Role	  of	  brain-­‐derived	  neurotrophic	  factor	  in	  the	  aetiology	  of	  depression:	  implications	  for	  pharmacological	  treatment.	  CNS	  drugs	  24:	  1-­‐7	  Cazorla	  M,	  Premont	  J,	  Mann	  A,	  Girard	  N,	  Kellendonk	  C,	  Rognan	  D.	  2011.	  Identification	  of	  a	  low-­‐molecular	  weight	  TrkB	  antagonist	  with	  anxiolytic	  and	  antidepressant	  activity	  in	  mice.	  The	  Journal	  of	  clinical	  investigation	  121:	  1846-­‐57	  Chao	  MV,	  Rajagopal	  R,	  Lee	  FS.	  2006.	  Neurotrophin	  signalling	  in	  health	  and	  disease.	  Clinical	  
science	  110:	  167-­‐73	  Choi	  DC,	  Gourley	  SL,	  Ressler	  KJ.	  2012.	  Prelimbic	  BDNF	  and	  TrkB	  signaling	  regulates	  consolidation	  of	  both	  appetitive	  and	  aversive	  emotional	  learning.	  Translational	  
psychiatry	  2:	  e205	  Choi	  DC,	  Maguschak	  KA,	  Ye	  K,	  Jang	  SW,	  Myers	  KM,	  Ressler	  KJ.	  2010.	  Prelimbic	  cortical	  BDNF	  is	  required	  for	  memory	  of	  learned	  fear	  but	  not	  extinction	  or	  innate	  fear.	  
Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  107:	  2675-­‐80	  
25 
Chrousos	  GP.	  2009.	  Stress	  and	  disorders	  of	  the	  stress	  system.	  Nature	  reviews.	  
Endocrinology	  5:	  374-­‐81	  Cooper	  MA,	  Huhman	  KL.	  2005.	  Corticotropin-­‐releasing	  factor	  type	  II	  (CRF-­‐sub-­‐2)	  receptors	  in	  the	  bed	  nucleus	  of	  the	  stria	  terminalis	  modulate	  conditioned	  defeat	  in	  Syrian	  hamsters	  (Mesocricetus	  auratus).	  Behavioral	  neuroscience	  119:	  1042-­‐51	  Cooper	  MA,	  Huhman	  KL.	  2007.	  Corticotropin-­‐releasing	  factor	  receptors	  in	  the	  dorsal	  raphe	  nucleus	  modulate	  social	  behavior	  in	  Syrian	  hamsters.	  Psychopharmacology	  194:	  297-­‐307	  Day	  DE,	  Cooper	  MA,	  Markham	  CM,	  Huhman	  KL.	  2011.	  NR2B	  subunit	  of	  the	  NMDA	  receptor	  in	  the	  basolateral	  amygdala	  is	  necessary	  for	  the	  acquisition	  of	  conditioned	  defeat	  in	  Syrian	  hamsters.	  Behavioural	  brain	  research	  217:	  55-­‐9	  Dell'Osso	  L,	  Carmassi	  C,	  Del	  Debbio	  A,	  Catena	  Dell'Osso	  M,	  Bianchi	  C,	  et	  al.	  2009.	  Brain-­‐derived	  neurotrophic	  factor	  plasma	  levels	  in	  patients	  suffering	  from	  post-­‐traumatic	  stress	  disorder.	  Progress	  in	  neuro-­‐psychopharmacology	  &	  biological	  psychiatry	  33:	  899-­‐902	  Dickerson	  SS,	  Kemeny	  ME.	  2004.	  Acute	  stressors	  and	  cortisol	  responses:	  a	  theoretical	  integration	  and	  synthesis	  of	  laboratory	  research.	  Psychological	  bulletin	  130:	  355-­‐91	  Duman	  RS,	  Monteggia	  LM.	  2006.	  A	  neurotrophic	  model	  for	  stress-­‐related	  mood	  disorders.	  
Biological	  psychiatry	  59:	  1116-­‐27	  Dwivedi	  Y.	  2010.	  Brain-­‐derived	  neurotrophic	  factor	  and	  suicide	  pathogenesis.	  Annals	  of	  
medicine	  42:	  87-­‐96	  Epel	  ES,	  Blackburn	  EH,	  Lin	  J,	  Dhabhar	  FS,	  Adler	  NE,	  et	  al.	  2004.	  Accelerated	  telomere	  shortening	  in	  response	  to	  life	  stress.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  
of	  the	  United	  States	  of	  America	  101:	  17312-­‐5	  Erk	  S,	  Mikschl	  A,	  Stier	  S,	  Ciaramidaro	  A,	  Gapp	  V,	  et	  al.	  2010.	  Acute	  and	  sustained	  effects	  of	  cognitive	  emotion	  regulation	  in	  major	  depression.	  The	  Journal	  of	  neuroscience	  :	  the	  
official	  journal	  of	  the	  Society	  for	  Neuroscience	  30:	  15726-­‐34	  Fanous	  S,	  Hammer	  RP,	  Jr.,	  Nikulina	  EM.	  2010.	  Short-­‐	  and	  long-­‐term	  effects	  of	  intermittent	  social	  defeat	  stress	  on	  brain-­‐derived	  neurotrophic	  factor	  expression	  in	  mesocorticolimbic	  brain	  regions.	  Neuroscience	  167:	  598-­‐607	  Gabbott	  PL,	  Warner	  TA,	  Jays	  PR,	  Salway	  P,	  Busby	  SJ.	  2005.	  Prefrontal	  cortex	  in	  the	  rat:	  projections	  to	  subcortical	  autonomic,	  motor,	  and	  limbic	  centers.	  The	  Journal	  of	  
comparative	  neurology	  492:	  145-­‐77	  Ghiadoni	  L,	  Donald	  AE,	  Cropley	  M,	  Mullen	  MJ,	  Oakley	  G,	  et	  al.	  2000.	  Mental	  stress	  induces	  transient	  endothelial	  dysfunction	  in	  humans.	  Circulation	  102:	  2473-­‐8	  Gilbert	  P,	  Allan	  S.	  1998.	  The	  role	  of	  defeat	  and	  entrapment	  (arrested	  flight)	  in	  depression:	  an	  exploration	  of	  an	  evolutionary	  view.	  Psychological	  medicine	  28:	  585-­‐98	  Hamilton	  JP,	  Gotlib	  IH.	  2008.	  Neural	  substrates	  of	  increased	  memory	  sensitivity	  for	  negative	  stimuli	  in	  major	  depression.	  Biological	  psychiatry	  63:	  1155-­‐62	  Heim	  C,	  Nemeroff	  CB.	  2001.	  The	  role	  of	  childhood	  trauma	  in	  the	  neurobiology	  of	  mood	  and	  anxiety	  disorders:	  preclinical	  and	  clinical	  studies.	  Biological	  psychiatry	  49:	  1023-­‐39	  Hoffman	  DL,	  Dukes	  EM,	  Wittchen	  HU.	  2008.	  Human	  and	  economic	  burden	  of	  generalized	  anxiety	  disorder.	  Depression	  and	  anxiety	  25:	  72-­‐90	  Huang	  EJ,	  Reichardt	  LF.	  2003.	  Trk	  receptors:	  roles	  in	  neuronal	  signal	  transduction.	  Annual	  
review	  of	  biochemistry	  72:	  609-­‐42	  
26 
Huhman	  KL,	  Bunnell	  BN,	  Mougey	  EH,	  Meyerhoff	  JL.	  1990.	  Effects	  of	  social	  conflict	  on	  POMC-­‐derived	  peptides	  and	  glucocorticoids	  in	  male	  golden	  hamsters.	  Physiology	  &	  
behavior	  47:	  949-­‐56	  Huhman	  KL,	  Hebert	  MA,	  Meyerhoff	  JL,	  Bunnell	  BN.	  1991a.	  Plasma	  cyclic	  AMP	  increases	  in	  hamsters	  following	  exposure	  to	  a	  graded	  footshock	  stressor.	  
Psychoneuroendocrinology	  16:	  559-­‐63	  Huhman	  KL,	  Moore	  TO,	  Ferris	  CF,	  Mougey	  EH,	  Meyerhoff	  JL.	  1991b.	  Acute	  and	  repeated	  exposure	  to	  social	  conflict	  in	  male	  golden	  hamsters:	  increases	  in	  plasma	  POMC-­‐peptides	  and	  cortisol	  and	  decreases	  in	  plasma	  testosterone.	  Hormones	  and	  behavior	  25:	  206-­‐16	  Huhman	  KL,	  Moore	  TO,	  Mougey	  EH,	  Meyerhoff	  JL.	  1992.	  Hormonal	  responses	  to	  fighting	  in	  hamsters:	  separation	  of	  physical	  and	  psychological	  causes.	  Physiology	  &	  behavior	  51:	  1083-­‐6	  Huhman	  KL,	  Solomon	  MB,	  Janicki	  M,	  Harmon	  AC,	  Lin	  SM,	  et	  al.	  2003.	  Conditioned	  defeat	  in	  male	  and	  female	  Syrian	  hamsters.	  Hormones	  and	  behavior	  44:	  293-­‐9	  Ishikawa	  A,	  Nakamura	  S.	  2003.	  Convergence	  and	  interaction	  of	  hippocampal	  and	  amygdalar	  projections	  within	  the	  prefrontal	  cortex	  in	  the	  rat.	  The	  Journal	  of	  
neuroscience	  :	  the	  official	  journal	  of	  the	  Society	  for	  Neuroscience	  23:	  9987-­‐95	  Jang	  SW,	  Liu	  X,	  Yepes	  M,	  Shepherd	  KR,	  Miller	  GW,	  et	  al.	  2010.	  A	  selective	  TrkB	  agonist	  with	  potent	  neurotrophic	  activities	  by	  7,8-­‐dihydroxyflavone.	  Proceedings	  of	  the	  National	  
Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  107:	  2687-­‐92	  Jasnow	  AM,	  Huhman	  KL.	  2001.	  Activation	  of	  GABA(A)	  receptors	  in	  the	  amygdala	  blocks	  the	  acquisition	  and	  expression	  of	  conditioned	  defeat	  in	  Syrian	  hamsters.	  Brain	  research	  920:	  142-­‐50	  Jasnow	  AM,	  Shi	  C,	  Israel	  JE,	  Davis	  M,	  Huhman	  KL.	  2005.	  Memory	  of	  social	  defeat	  is	  facilitated	  by	  cAMP	  response	  element-­‐binding	  protein	  overexpression	  in	  the	  amygdala.	  Behavioral	  neuroscience	  119:	  1125-­‐30	  Kalia	  M.	  2002.	  Assessing	  the	  economic	  impact	  of	  stress-­‐-­‐the	  modern	  day	  hidden	  epidemic.	  
Metabolism:	  clinical	  and	  experimental	  51:	  49-­‐53	  Karege	  F,	  Perret	  G,	  Bondolfi	  G,	  Schwald	  M,	  Bertschy	  G,	  Aubry	  JM.	  2002.	  Decreased	  serum	  brain-­‐derived	  neurotrophic	  factor	  levels	  in	  major	  depressed	  patients.	  Psychiatry	  
research	  109:	  143-­‐8	  Kelleher	  I,	  Harley	  M,	  Lynch	  F,	  Arseneault	  L,	  Fitzpatrick	  C,	  Cannon	  M.	  2008.	  Associations	  between	  childhood	  trauma,	  bullying	  and	  psychotic	  symptoms	  among	  a	  school-­‐based	  adolescent	  sample.	  The	  British	  journal	  of	  psychiatry	  :	  the	  journal	  of	  mental	  science	  193:	  378-­‐82	  Koizumi	  S,	  Contreras	  ML,	  Matsuda	  Y,	  Hama	  T,	  Lazarovici	  P,	  Guroff	  G.	  1988.	  K-­‐252a:	  a	  specific	  inhibitor	  of	  the	  action	  of	  nerve	  growth	  factor	  on	  PC	  12	  cells.	  The	  Journal	  of	  
neuroscience	  :	  the	  official	  journal	  of	  the	  Society	  for	  Neuroscience	  8:	  715-­‐21	  Kollack-­‐Walker	  S,	  Don	  C,	  Watson	  SJ,	  Akil	  H.	  1999.	  Differential	  expression	  of	  c-­‐fos	  mRNA	  within	  neurocircuits	  of	  male	  hamsters	  exposed	  to	  acute	  or	  chronic	  defeat.	  Journal	  of	  
neuroendocrinology	  11:	  547-­‐59	  Kollack-­‐Walker	  S,	  Watson	  SJ,	  Akil	  H.	  1997.	  Social	  stress	  in	  hamsters:	  defeat	  activates	  specific	  neurocircuits	  within	  the	  brain.	  The	  Journal	  of	  neuroscience	  :	  the	  official	  
journal	  of	  the	  Society	  for	  Neuroscience	  17:	  8842-­‐55	  
27 
Koolhaas	  JM,	  Coppens	  CM,	  de	  Boer	  SF,	  Buwalda	  B,	  Meerlo	  P,	  Timmermans	  PJ.	  2013.	  The	  resident-­‐intruder	  paradigm:	  a	  standardized	  test	  for	  aggression,	  violence	  and	  social	  stress.	  Journal	  of	  visualized	  experiments	  :	  JoVE:	  e4367	  Lehmann	  ML,	  Herkenham	  M.	  2011.	  Environmental	  enrichment	  confers	  stress	  resiliency	  to	  social	  defeat	  through	  an	  infralimbic	  cortex-­‐dependent	  neuroanatomical	  pathway.	  
The	  Journal	  of	  neuroscience	  :	  the	  official	  journal	  of	  the	  Society	  for	  Neuroscience	  31:	  6159-­‐73	  Marek	  R,	  Strobel	  C,	  Bredy	  TW,	  Sah	  P.	  2013.	  The	  amygdala	  and	  medial	  prefrontal	  cortex:	  partners	  in	  the	  fear	  circuit.	  The	  Journal	  of	  physiology	  591:	  2381-­‐91	  Markham	  CM,	  Huhman	  KL.	  2008.	  Is	  the	  medial	  amygdala	  part	  of	  the	  neural	  circuit	  modulating	  conditioned	  defeat	  in	  Syrian	  hamsters?	  Learning	  &	  memory	  15:	  6-­‐12	  Markham	  CM,	  Luckett	  CA,	  Huhman	  KL.	  2012.	  The	  medial	  prefrontal	  cortex	  is	  both	  necessary	  and	  sufficient	  for	  the	  acquisition	  of	  conditioned	  defeat.	  
Neuropharmacology	  62:	  933-­‐9	  Markham	  CM,	  Norvelle	  A,	  Huhman	  KL.	  2009.	  Role	  of	  the	  bed	  nucleus	  of	  the	  stria	  terminalis	  in	  the	  acquisition	  and	  expression	  of	  conditioned	  defeat	  in	  Syrian	  hamsters.	  
Behavioural	  brain	  research	  198:	  69-­‐73	  Markham	  CM,	  Taylor	  SL,	  Huhman	  KL.	  2010.	  Role	  of	  amygdala	  and	  hippocampus	  in	  the	  neural	  circuit	  subserving	  conditioned	  defeat	  in	  Syrian	  hamsters.	  Learning	  &	  memory	  17:	  109-­‐16	  McDonald	  MM,	  Markham	  CM,	  Norvelle	  A,	  Albers	  HE,	  Huhman	  KL.	  2012.	  GABAA	  receptor	  activation	  in	  the	  lateral	  septum	  reduces	  the	  expression	  of	  conditioned	  defeat	  and	  increases	  aggression	  in	  Syrian	  hamsters.	  Brain	  research	  1439:	  27-­‐33	  McEwen	  BS,	  Stellar	  E.	  1993.	  Stress	  and	  the	  individual.	  Mechanisms	  leading	  to	  disease.	  
Archives	  of	  internal	  medicine	  153:	  2093-­‐101	  Milad	  MR,	  Quirk	  GJ.	  2002.	  Neurons	  in	  medial	  prefrontal	  cortex	  signal	  memory	  for	  fear	  extinction.	  Nature	  420:	  70-­‐4	  Milad	  MR,	  Vidal-­‐Gonzalez	  I,	  Quirk	  GJ.	  2004.	  Electrical	  stimulation	  of	  medial	  prefrontal	  cortex	  reduces	  conditioned	  fear	  in	  a	  temporally	  specific	  manner.	  Behavioral	  
neuroscience	  118:	  389-­‐94	  Minichiello	  L.	  2009.	  TrkB	  signalling	  pathways	  in	  LTP	  and	  learning.	  Nature	  reviews.	  
Neuroscience	  10:	  850-­‐60	  Morrison	  KE,	  Bader	  LR,	  McLaughlin	  CN,	  Cooper	  MA.	  2013.	  Defeat-­‐induced	  activation	  of	  the	  ventral	  medial	  prefrontal	  cortex	  is	  necessary	  for	  resistance	  to	  conditioned	  defeat.	  
Behavioural	  brain	  research	  243:	  158-­‐64	  Morrison	  KE,	  Curry	  DW,	  Cooper	  MA.	  2012.	  Social	  status	  alters	  defeat-­‐induced	  neural	  activation	  in	  Syrian	  hamsters.	  Neuroscience	  210:	  168-­‐78	  NIH.	  Major	  Depression	  Among	  Adults.	  	  NIH.	  Post-­‐Traumatic	  Stress	  Disorder	  Among	  Adults.	  	  Nikulina	  EM,	  Lacagnina	  MJ,	  Fanous	  S,	  Wang	  J,	  Hammer	  RP,	  Jr.	  2012.	  Intermittent	  social	  defeat	  stress	  enhances	  mesocorticolimbic	  DeltaFosB/BDNF	  co-­‐expression	  and	  persistently	  activates	  corticotegmental	  neurons:	  implication	  for	  vulnerability	  to	  psychostimulants.	  Neuroscience	  212:	  38-­‐48	  Ongur	  D,	  Price	  JL.	  2000.	  The	  organization	  of	  networks	  within	  the	  orbital	  and	  medial	  prefrontal	  cortex	  of	  rats,	  monkeys	  and	  humans.	  Cerebral	  cortex	  10:	  206-­‐19	  
28 
Pego	  JM,	  Sousa	  JC,	  Almeida	  OF,	  Sousa	  N.	  2010.	  Stress	  and	  the	  neuroendocrinology	  of	  anxiety	  disorders.	  Current	  topics	  in	  behavioral	  neurosciences	  2:	  97-­‐117	  Peters	  J,	  Dieppa-­‐Perea	  LM,	  Melendez	  LM,	  Quirk	  GJ.	  2010.	  Induction	  of	  fear	  extinction	  with	  hippocampal-­‐infralimbic	  BDNF.	  Science	  328:	  1288-­‐90	  Pizarro	  JM,	  Lumley	  LA,	  Medina	  W,	  Robison	  CL,	  Chang	  WE,	  et	  al.	  2004.	  Acute	  social	  defeat	  reduces	  neurotrophin	  expression	  in	  brain	  cortical	  and	  subcortical	  areas	  in	  mice.	  
Brain	  research	  1025:	  10-­‐20	  Potegal	  M,	  Huhman	  K,	  Moore	  T,	  Meyerhoff	  J.	  1993.	  Conditioned	  defeat	  in	  the	  Syrian	  golden	  hamster	  (Mesocricetus	  auratus).	  Behavioral	  and	  neural	  biology	  60:	  93-­‐102	  Rakofsky	  JJ,	  Ressler	  KJ,	  Dunlop	  BW.	  2012.	  BDNF	  function	  as	  a	  potential	  mediator	  of	  bipolar	  disorder	  and	  post-­‐traumatic	  stress	  disorder	  comorbidity.	  Molecular	  psychiatry	  17:	  22-­‐35	  Reichardt	  LF.	  2006.	  Neurotrophin-­‐regulated	  signalling	  pathways.	  Philosophical	  transactions	  
of	  the	  Royal	  Society	  of	  London.	  Series	  B,	  Biological	  sciences	  361:	  1545-­‐64	  Rive	  MM,	  van	  Rooijen	  G,	  Veltman	  DJ,	  Phillips	  ML,	  Schene	  AH,	  Ruhe	  HG.	  2013.	  Neural	  correlates	  of	  dysfunctional	  emotion	  regulation	  in	  major	  depressive	  disorder.	  A	  systematic	  review	  of	  neuroimaging	  studies.	  Neuroscience	  and	  biobehavioral	  reviews	  37:	  2529-­‐53	  Russ	  TC,	  Stamatakis	  E,	  Hamer	  M,	  Starr	  JM,	  Kivimaki	  M,	  Batty	  GD.	  2012.	  Association	  between	  psychological	  distress	  and	  mortality:	  individual	  participant	  pooled	  analysis	  of	  10	  prospective	  cohort	  studies.	  Bmj	  345:	  e4933	  Saarelainen	  T,	  Hendolin	  P,	  Lucas	  G,	  Koponen	  E,	  Sairanen	  M,	  et	  al.	  2003.	  Activation	  of	  the	  TrkB	  neurotrophin	  receptor	  is	  induced	  by	  antidepressant	  drugs	  and	  is	  required	  for	  antidepressant-­‐induced	  behavioral	  effects.	  The	  Journal	  of	  neuroscience	  :	  the	  official	  
journal	  of	  the	  Society	  for	  Neuroscience	  23:	  349-­‐57	  Sakata	  K,	  Martinowich	  K,	  Woo	  NH,	  Schloesser	  RJ,	  Jimenez	  DV,	  et	  al.	  2013.	  Role	  of	  activity-­‐dependent	  BDNF	  expression	  in	  hippocampal-­‐prefrontal	  cortical	  regulation	  of	  behavioral	  perseverance.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  
United	  States	  of	  America	  110:	  15103-­‐8	  Segerstrom	  SC,	  Miller	  GE.	  2004.	  Psychological	  stress	  and	  the	  human	  immune	  system:	  a	  meta-­‐analytic	  study	  of	  30	  years	  of	  inquiry.	  Psychological	  bulletin	  130:	  601-­‐30	  Shin	  LM,	  Liberzon	  I.	  2010.	  The	  neurocircuitry	  of	  fear,	  stress,	  and	  anxiety	  disorders.	  
Neuropsychopharmacology	  :	  official	  publication	  of	  the	  American	  College	  of	  
Neuropsychopharmacology	  35:	  169-­‐91	  Sierra-­‐Mercado	  D,	  Padilla-­‐Coreano	  N,	  Quirk	  GJ.	  2011.	  Dissociable	  roles	  of	  prelimbic	  and	  infralimbic	  cortices,	  ventral	  hippocampus,	  and	  basolateral	  amygdala	  in	  the	  expression	  and	  extinction	  of	  conditioned	  fear.	  Neuropsychopharmacology	  :	  official	  
publication	  of	  the	  American	  College	  of	  Neuropsychopharmacology	  36:	  529-­‐38	  Sofroniew	  MV,	  Howe	  CL,	  Mobley	  WC.	  2001.	  Nerve	  growth	  factor	  signaling,	  neuroprotection,	  and	  neural	  repair.	  Annual	  review	  of	  neuroscience	  24:	  1217-­‐81	  Suliman	  S,	  Hemmings	  SM,	  Seedat	  S.	  2013.	  Brain-­‐Derived	  Neurotrophic	  Factor	  (BDNF)	  protein	  levels	  in	  anxiety	  disorders:	  systematic	  review	  and	  meta-­‐regression	  analysis.	  
Frontiers	  in	  integrative	  neuroscience	  7:	  55	  Tamashiro	  KL,	  Nguyen	  MM,	  Sakai	  RR.	  2005.	  Social	  stress:	  from	  rodents	  to	  primates.	  
Frontiers	  in	  neuroendocrinology	  26:	  27-­‐40	  
29 
Taylor	  SL,	  Stanek	  LM,	  Ressler	  KJ,	  Huhman	  KL.	  2011.	  Differential	  brain-­‐derived	  neurotrophic	  factor	  expression	  in	  limbic	  brain	  regions	  following	  social	  defeat	  or	  territorial	  aggression.	  Behavioral	  neuroscience	  125:	  911-­‐20	  Trivedi	  MH,	  Fava	  M,	  Wisniewski	  SR,	  Thase	  ME,	  Quitkin	  F,	  et	  al.	  2006a.	  Medication	  augmentation	  after	  the	  failure	  of	  SSRIs	  for	  depression.	  The	  New	  England	  journal	  of	  
medicine	  354:	  1243-­‐52	  Trivedi	  MH,	  Rush	  AJ,	  Wisniewski	  SR,	  Nierenberg	  AA,	  Warden	  D,	  et	  al.	  2006b.	  Evaluation	  of	  outcomes	  with	  citalopram	  for	  depression	  using	  measurement-­‐based	  care	  in	  STAR*D:	  implications	  for	  clinical	  practice.	  The	  American	  journal	  of	  psychiatry	  163:	  28-­‐40	  Vertes	  RP.	  2004.	  Differential	  projections	  of	  the	  infralimbic	  and	  prelimbic	  cortex	  in	  the	  rat.	  
Synapse	  51:	  32-­‐58	  Vialou	  V,	  Bagot	  RC,	  Cahill	  ME,	  Ferguson	  D,	  Robison	  AJ,	  et	  al.	  2014.	  Prefrontal	  cortical	  circuit	  for	  depression-­‐	  and	  anxiety-­‐related	  behaviors	  mediated	  by	  cholecystokinin:	  role	  of	  DeltaFosB.	  The	  Journal	  of	  neuroscience	  :	  the	  official	  journal	  of	  the	  Society	  for	  
Neuroscience	  34:	  3878-­‐87	  Vidal-­‐Gonzalez	  I,	  Vidal-­‐Gonzalez	  B,	  Rauch	  SL,	  Quirk	  GJ.	  2006.	  Microstimulation	  reveals	  opposing	  influences	  of	  prelimbic	  and	  infralimbic	  cortex	  on	  the	  expression	  of	  conditioned	  fear.	  Learning	  &	  memory	  13:	  728-­‐33	  WHO.	  2008.	  The	  Global	  Burden	  of	  Disease:	  2004	  Update.	  Geneva,	  Switzerland:	  WHO	  Press	  Yoshii	  A,	  Constantine-­‐Paton	  M.	  2010.	  Postsynaptic	  BDNF-­‐TrkB	  signaling	  in	  synapse	  maturation,	  plasticity,	  and	  disease.	  Developmental	  neurobiology	  70:	  304-­‐22	  Zhou	  XF,	  Chie	  ET,	  Rush	  RA.	  1998.	  Distribution	  of	  brain-­‐derived	  neurotrophic	  factor	  in	  cranial	  and	  spinal	  ganglia.	  Exp	  Neurol	  149:	  237-­‐42	  Zhou	  XF,	  Parada	  LF,	  Soppet	  D,	  Rush	  RA.	  1993.	  Distribution	  of	  trkB	  tyrosine	  kinase	  immunoreactivity	  in	  the	  rat	  central	  nervous	  system.	  Brain	  research	  622:	  63-­‐70	  
 	  	  	  
 
 
  
30 
1.2 Figures 
 
 
Figure 1.1 Putative Circuit Mediating the Acquisition and Expression of Conditioned Defeat 
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2 BDNF REDUCES BEHAVIORAL RESPONSES TO SOCIAL STRESS IN SYRIAN 
HAMSTERS  
2.1 Abstract 
Brain derived neurotrophic factor (BDNF) via its action at its cognate receptor, TrkB, 
promotes learning and synaptic plasticity. Peripheral administration of 7,8-Dihydroxyflavone 
(7,8-DHF), a novel TrkB receptor agonist, increases conditioned fear learning following cued 
fear conditioning. Furthermore, our lab has demonstrated that a non-specific Trk receptor 
antagonist administered into the BLA prior to defeat reduces later submission, suggesting that 
neurotrophins are also necessary for fear learning in social situations and that defeat-induced 
behavioral changes are mediated at least in part in the BLA.  The purpose of this study was to 
test whether BDNF acts via TrkB receptors to promote conditioned defeat, and if so, to test 
whether BDNF acts directly in the BLA. First, we administered rhBDNF (0.2ng/200nl; 
0.4ng/200nl) directly into the BLA immediately prior to defeat and found that BDNF reduced 
submission in defeated hamsters when they were tested 24 h after defeat training. Similarly, the 
specific TrkB receptor agonist 7,8-DHF given immediately prior to (0.0, 2.5; 5.0; 10mg/kg IP) or 
immediately after (0.0; 10mg/kg IP) defeat training also reduced submission in defeated 
hamsters during testing. Finally, we demonstrated that the TrkB receptor antagonist ANA-12 
(0.0; 0.5; 1mg/kg IP) enhanced submission during testing. Counter to our prediction that BDNF 
acting at TrkB receptors would promote CD learning, these results suggest that BDNF is a 
molecule that can reduce behavioral responses to stress and may thus promote a state of 
resistance to stress. 
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2.2 Introduction 
Brain derived neurotrophic factor (BDNF) has gained increasing attention for its role in 
stress responding, learning, and memory (Chao et al., 2006; Minichiello, 2009; Adachi et al., 
2014). This protein binds to tyrosine kinase B (TrkB) receptors in both brain (e.g., cerebral 
cortex, basal forebrain, striatum and hippocampus) and periphery, and BDNF is known to be 
involved in neuron growth, plasticity, and synapse development (Conner et al., 1997; Chao et al., 
2006; Minichiello, 2009). Of particular interest is the role of BDNF in synaptogenesis and long-
term potentiation (see Cunha et al., 2010 for review), as it appears that BDNF enhances long-
term memory (LTM) (e.g., fear learning). Furthermore, BDNF and LTM are both altered by 
stress (Yang et al., 2013; see Pittenger & Duman, 2008 for review), thus leading to complex and 
context-dependent changes in brain and behavior. It is therefore not surprising that the 
intersection of BDNF, learning, and stress has gained increasing attention, especially given the 
potential clinical applications (e.g., potential treatment of mood and anxiety disorders). As the 
data regarding BDNF converges between different scientific subfields, it appears that there is 
support for 2 seemingly opposing ways that BDNF can alter the response to stressful 
experiences: one promoting fear learning and the other suggesting that BDNF is a molecule that 
reduces the effects of stress and instead promotes resiliency.  
A large body of research indicates that BDNF/TrkB signaling is necessary for fear 
learning in several nuclei including the mPFC and the amygdala (reviewed in Mahan & Ressler, 
2012). Pre-training administration of a non-specific Trk receptor antagonist directly into the 
BLA decreases subsequent fear-potentiated startle, suggesting that BDNF/TrkB signaling within 
the BLA is necessary for the acquisition of conditioned fear (Rattiner et al., 2004; reviewed in 
Mahan & Ressler, 2012). Similarly, we have demonstrated that k252a, a non-specific Trk 
receptor antagonist, administered directly into the BLA prior to defeat reduces submissive 
behavior 24 h later during testing (Taylor et al., 2011). The finding that BDNF is also necessary 
for the consolidation of fear learning is confirmed in several site-specific BDNF knockout 
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models that demonstrate that BDNF in the mPFC is necessary for fear learning (Choi et al., 
2010; Choi et al., 2012). These studies clearly support the idea that BDNF promotes learning 
and the acquisition or consolidation of conditioned fear.  
Furthermore, BDNF is altered in circuits that are important for fear learning and in 
nuclei that are stress responsive. For example, chronic stress in rats and repeated social stress in 
mice increases BDNF protein in the amygdala (Lakshminarasimhan & Chattarji, 2012; see also 
review by Boyle, 2013). Ten days of social defeat stress in mice increases BDNF protein levels in 
the nucleus accumbens (NAc) 24 h and 4 weeks later (Berton et al., 2006). Our lab has also 
reported that BDNF mRNA is increased in the BLA 24 h after social defeat. However, these 
results conflict with other reports that stress instead decreases BDNF protein or mRNA. Fanous 
and colleagues, for example, report that social stress decreases BDNF protein in the amygdala 
(Fanous et al., 2010). BDNF mRNA is also reported to decrease in the BLA 24 h after social 
defeat stress in mice (Pizarro et al., 2004). It is clear the BDNF changes in response to stressful 
experiences, but the directionality of these changes is not at all certain.   
In opposition to its role in promoting fear learning, there is also evidence to suggest 
BDNF is protective against stress-induced behavioral changes. One of the most exciting frontiers 
in the field of depression research is the finding that BDNF may play a key role in this 
debilitating disorder. BDNF is suppressed following exposure to stress in humans, and reduced 
BDNF protein in serum is observed in patients with numerous psychiatric illnesses, including 
major depressive disorder (Karege et al., 2002; reviewed by Duman & Monteggia, 2006; Castren 
& Rantamaki, 2010), posttraumatic stress disorder (PTSD) (Dell’osso et al., 2009; review by 
Rakofsky et al., 2012; Suliman, Hemmings, & Seedat, 2013), as well as in blood cells of suicidal 
patients (Dwivedi, 2010). Numerous labs using animal models have reported that BDNF is 
increased following antidepressant treatment (Karege et al., 2002; reviewed by Duman and 
Monteggia, 2006; Castren & Rantamaki, 2010; Suliman, Hemmings, & Seedat, 2013). 
Furthermore, blocking BDNF receptor activation in the prefrontal cortex prevents 
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antidepressant effects in mice as measured in the forced swim test (Saarelinen et al., 2003). 
These data suggest that BDNF is a molecule that promotes “stress resilience”, as defined by a 
reduced behavioral response to stress, and that alterations of this neurotrophin system is one of 
the mechanisms that underlies the effectiveness of antidepressants.  
 Given the apparent contradictions regarding the role of BDNF in stress and LTM, it is 
important that additional work be completed. One model that may help to clarify the role of 
BDNF is conditioned defeat (CD), which refers to the increase in submissive behavior that is 
observed following a social defeat experience. CD can be viewed as an ethologically relevant 
model of fear conditioning, and many of the manipulations that alter fear conditioning also alter 
CD similarly. Given the literature supporting a role for BDNF in fear conditioning, we expected 
BDNF to promote CD learning as evidenced by increasing submission following social defeat. 
This finding would be consistent with our previous findings that BDNF mRNA increases in the 
BLA following defeat and that a non-specific TrkB antagonist in the BLA decreases the 
acquisition of CD. The purpose of this project was therefore to clarify the role of BDNF in 
behavioral responses to social stress following the site-specific injection of BDNF into the BLA 
and following peripheral administration of a selective TrkB receptor agonist and antagonist.  
 
2.3 Materials & Methods  
2.3.1 Animals & Housing Conditions  
Subjects in all experiments were male Syrian hamsters (Mesocricetus auratus, Charles 
River Laboratories, New York, NY) that weighed 120-140 g and were between 9-10 weeks old at 
the time of testing. All hamsters were handled for five days prior to behavioral procedures to 
acclimate them to experimenter handling and were singly housed in polycarbonate cages (20x 
40 x 20cm) with corncob bedding and wire mesh tops in a temperature (20 ± 2° C) and 
humidity controlled room. The colony room was maintained on a 14:10 light: dark cycle with 
lights off at 10:00 am. Food and water were available ad libitum. Older hamsters (>6 months), 
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which were individually housed (>1 month) and weighed at least 180g served as resident 
aggressors (RA) in defeat training, whereas smaller (110g-120g), younger (~ 7 weeks) hamsters 
were group housed and served as non-aggressive intruders (NAI) during CD testing. All 
procedures and protocols were approved by the Georgia State University Institutional Animal 
Care and Use Committee and are in accordance with the standards outlined in the National 
Institutes of Health Guide for Care and Use of Laboratory Animals. 
 
2.3.2 Surgical Procedures  
Subjects in Experiment 1 were deeply anesthetized via exposure to 5% isoflurane mixed 
with 100% oxygen, placed in a stereotaxic frame, and maintained under anesthesia for the 
duration of the cannula implantation surgery via a nose cone that delivered 2-3% isoflurane. 
Breathing and body temperature were monitored while animals were under anesthesia. 4mm, 
26-gauge guide cannulae (Plastics One, Roanoke, VA) were bilaterally implanted and aimed at 
the BLA using the following stereotaxic coordinates: 0.2mm posterior and ±3.8mm lateral to 
bregma and 1.9 mm below dura. During the injection procedure, a 33-gauge needle with a 4.2 
mm projection from the base of the cannula guide was lowered into the BLA to give a final 
dorsal-ventral depth of 6.3mm. This was done in order to minimize tissue damage in and around 
the amygdala. Lambda and bregma were leveled prior to placement of the guide cannula. 
Following surgery, dummy stylets were placed in the guide cannula to help maintain patency, 
and 1 cc of physiological saline and 0.1 cc of ketoprofen were injected subcutaneously in order to 
aid in recovery. Hamsters were allowed 5-7 days to recover prior to the start of behavioral 
testing during which time they were monitored daily to ensure that there were no adverse 
outcomes from the surgery.   
2.3.3 Social Defeat & Behavioral Testing  
The CD model has been described in detail elsewhere (Huhman et al., 2003). Prior to 
training, hamsters were matched by weight and then randomly assigned to groups. All animals 
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were transported in their home cage to the behavioral testing suite in the animal vivarium 30 
min prior to all behavioral manipulations in order to acclimate. All behavioral procedures were 
performed in the first 3 h of the dark phase of the daily light: dark cycle to minimize any 
circadian effects. Social defeat training occurred in the home cage of the RA for 15 min 
(Experiment 1) or 5 min (Experiments 2a, 2b, & 3). In all experiments, no-defeat controls were 
placed into an empty RA cage to expose animals to odors but no physical interaction. Behavioral 
testing occurred 24 h after training when an NAI was placed in the home cage of the 
experimental animal for a 5 min test.  
2.3.4 Behavioral Analysis  
All social defeat training and behavioral testing was recorded via video camera, 
transferred to an external hard drive, and later scored by a observer blind to experimental 
condition using Observer for Windows (Noldus Information Technology B.V., Wageningen, The 
Netherlands; version 7.0). Total durations for 4 classes of behavior were scored during testing 
including: (1) Social (stretch, approach, sniff, nose touching, and flank marking); (2) Non-social 
(locomotion, exploration, grooming, nesting, feeding and sleeping); (3) Submissive (flight, 
avoidance, tail up, upright and side defense, full submissive posture, stretch attend, attempted 
escape from cage); and (4) Aggressive (upright and side offense, chase and attack, including 
bite). In Experiment 3 wherein the drug treatment was given before the initial social defeat, the 
behavior of the resident aggressors and subjects was also scored during training to ensure that 
(1) all animals received similar defeats, and (2) all subjects were able to produce normal 
submissive behavior in response to attack. 
2.3.5 Drug Administration  
In Experiment 1, rhBDNF (Sigma; St. Louis, MO) dissolved in physiological saline was 
administered via microinjection bilaterally into the BLA to freely moving hamsters immediately 
prior to defeat. All microinjections were administered over 2 min using a 33-gauge injection 
needle connected via polyethylene tubing to a Hamilton syringe. Hamilton syringes were 
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mounted on a syringe pump (Harvard Apparatus). The 2 dosages (0.2ng/200 nl; 0.4ng/200 nl) 
administered were based on previous work using site-specific microinjections of rhBDNF in rats 
in the periaqueductal grey (Casarotto et al., 2010).  
In Experiments 2a & 2b, animals received either a TrkB receptor agonist, 7,8-
Dihydroxyflavone (7,8-DHF) (TCI America; Montgomeryville, PA) dissolved in 40% 
Dimethylsulfoxide (DMSO)/60% saline (Experiments 2a & 2b) or vehicle (40% DMSO /60% 
saline). Animals in Experiment 2a received 7,8-DHF (2.5mg/kg; 5mg/kg; 10mg/kg) or vehicle 
immediately prior to a 5min defeat. A dose response curve was based on dosages used 
previously (Andero et al., 2010; Andero et al., 2011). Animals in Experiment 2b received the 
effective dose (determined in Experiment 2a) of 7,8-DHF (10mg/kg) or vehicle immediately 
after a 5min defeat. Post-training administration of 7,8-DHF has been used previously (Andero 
et al., 2010). 
In Experiment 3, animals received either a TrkB receptor antagonist; ANA-12 
(0.5mg/kg; 1.0mg/kg;)  ([N2-2-2-Oxoazepan-3-yl amino] carbonyl phenyl benzo (b) thiophene-
2-carboxamide) (Sigma; St. Louis, MO) dissolved in 100% DMSO or vehicle (100% DMSO) 
immediately after a 5min defeat. Dosages of ANA-12 were obtained from the literature (Cazorla 
et al., 2011). Post-training drug administration was used in Experiments 2b and 3 because the 
TrkB drugs were only soluble in DMSO solutions, and these vehicle solutions caused the 
subjects to have an odor that was discernable to the investigators. Administration of one of the 
DMSO solutions after defeat does not interfere with conspecifc behavioral encounters.  
2.3.6 Site Verification  
At the conclusion of Experiment 1, animals were administered an overdose of sodium 
pentobarbital and were bilaterally infused with 200nl of India ink to verify needle placements. 
Brains were then removed and placed in 10% buffered formalin before being sectioned on a 
cryostat (Leica CM 3050 S). Sections were stained with Neutral red, cover slipped with DPX 
mountant, and examined using a light microscope for ink in the BLA. Only animals with 
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bilateral ink injections within 0.3mm of the BLA, as determined by 2 observers blind to 
experimental group, were included in the final analysis.  
 
2.3.7 Experiment 1: Does a microinjection of BDNF into the BLA enhance 
the acquisition of CD?  
The purpose of Experiment 1 was to determine whether infusion of BDNF into the BLA 
enhances the acquisition of CD. Animals (n=19) were randomly assigned to one of 3 defeat 
groups that received one of the 2 dosages (0.2ng/200 nl; 0.4ng/200 nl) of rhBDNF in 
physiological saline or vehicle (physiological saline). All injections were administered 
immediately prior to a 15 min defeat. Animals were tested drug free 24 h later in their home 
cage with an NAI for 5 min, as described above in Experiment 1.  
2.3.8  Experiment 2a: Does systemic injection of a TrkB receptor agonist 
enhance the acquisition of CD? 
The goal of Experiment 2a was to determine whether an IP injection of a specific TrkB 
receptor agonist, 7, 8-DHF enhances the acquisition of CD. We predicted that 7,8-DHF would 
increase submissive behavior despite the site-specific effects of BDNF in the BLA because 1) the 
strong evidence that BDNF is necessary for fear learning and 2) the possibility that BDNF might 
act in opposing ways within nodes of the conditioned defeat neural circuit and peripheral 
injections would result in an overall net effect of the drug (i.e., enhanced submission). Animals 
(n=42) were randomly assigned to one of 4 defeat groups that received one of 3 dosages of 7,8-
DHF (2.5mg/kg; 5mg/kg; 10mg/kg) dissolved in 40% Dimethylsulfoxide (DMSO) and 60% 
saline or vehicle (40% DMSO /60% saline) immediately prior to a 5 min defeat. A suboptimal 5 
min defeat was used in this experiment to avoid a potential ceiling effect because we had initially 
expected this treatment to enhance CD.  Animals were tested drug free 24 h later in their home 
cage with an NAI for 5 min, as described above in Experiment 1. 
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2.3.9 Experiment 2b: Does systemic injection of a TrkB receptor agonist 
enhance the consolidation of CD?  
Given the unexpected findings that BDNF and a TrkB agonist administered prior to 
defeat reduce submission (Experiments 1 & 2a), the goal of Experiment 2b was to determine 
whether an IP injection of a specific TrkB receptor agonist, 7, 8-DHF enhances the consolidation 
of CD. Animals (n=40) were randomly assigned to groups (defeat or no defeat) and within these 
2 conditions, animals received either 10mg/kg of 7,8-DHF dissolved in 40% Dimethylsulfoxide 
(DMSO) and 60% saline or vehicle (40% DMSO /60% saline) immediately after a 5 min defeat. 
A suboptimal 5 min defeat was used in this experiment to avoid a potential ceiling effect because 
we expected this treatment to enhance CD.  Animals were tested drug free 24 h later in their 
home cage with an NAI for 5 min, as described above in Experiment 1. 
2.3.10 Experiment 3: Does a systemic injection of a TrkB receptor 
antagonist reduce the consolidation of CD? 
Given the unexpected findings that BDNF and a TrkB agonist reduce submission 
(Experiments 1-2b), the goal of Experiment 3 was to determine whether an IP injection of a 
specific TrkB receptor antagonist, ANA-12, enhances the consolidation of CD. Animals (n=38) 
received either ANA-12 (1.0mg/kg; 0.5mg/kg) dissolved in 100% DMSO or vehicle (100% 
DMSO) immediately after a suboptimal, 5 min defeat. Within the aforementioned drug groups 
defeat experience (defeat vs. no-defeat) was also examined. Animals were tested drug free 24 h 
later in their home cage with an NAI for 5 min, as described above in Experiment 2b.  
2.3.11  Statistical Analysis 
The total duration (seconds) of submission, social and non-social behaviors were 
determined. All durations were converted and represented as percent of vehicle control for 
statistical analysis because the baseline submission following defeat was variable due to the 
different durations of defeat training and natural variation in the behavior among experiments. 
40 
An analysis of variance (ANOVA) was used to test differences in durations of behavior between 
groups. When the variances in our behavioral data violated homogeneity (Levene’s Test, 
P>0.05) or normality assumptions (normality of the behavioral data was examined using the 
Kolmogorov Smirnov test for Experiments 1, 2b, & 3), then non-parametric tests (Kruskal-
Wallis using Mann Whitney U for post-hoc analysis) were completed, when appropriate. 
Analyses were performed with IBM SPSS software (20.0.0). Criterion for significance was set to 
p<0.05.  
 
2.4 Results   
2.4.1 Experiment 1: BDNF infused into the BLA reduces the acquisition of 
CD  
Figure 1 shows the injections sites for all animals in Experiment 1, and Figure 2 is a 
photomicrograph of a representative coronal section of the BLA showing the location of the 
injection needle as indicated by ink injection.  
As shown in Figure 3, infusion of BDNF into the BLA prior to defeat training 
significantly reduced the display of submissive behaviors (Kruskal Wallis, p<0.05) in defeated 
hamsters that received BDNF as compared to those receiving vehicle when tested 24 h later. No 
significant differences were observed for aggressive, social, and non-social behaviors in defeated 
hamsters that received BDNF as compared to vehicle (Kruskal Wallis, p>0.05).  There were also 
no significant differences between drug and vehicle groups in the aggressive behavior produced 
by the RAs during defeat training or in the behavioral response exhibited by the experimental 
animals in response to attack (data not shown), indicating that rhBDNF did not alter the 
behavior of the RAs or the experimental animals during the initial defeat training. 
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2.4.2 Experiment 2a: 7, 8-DHF administered systemically reduces the 
acquisition of CD  
As shown in Figure 4, there was a main effect of drug on submission (F (3,39)=2.946, 
p<0.05) and on social behavior (F (3,39)=3.703, p<0.05). Least significant difference post-hoc 
tests revealed that hamsters receiving a 10mg/kg IP injection of 7,8-DHF prior to defeat 
displayed a significant decrease in submissive and defensive behavior when tested 24 h later as 
compared to animals receiving vehicle (p=0.007). Post-hoc tests also revealed that hamsters 
receiving a 10mg/kg IP injection of 7,8-DHF prior to defeat displayed a significant increase in 
social behaviors as compared to animals receiving vehicle (p=0.049). Animals receiving 
2.5mg/kg of 7,8-DHF prior to defeat also displayed a significant increase in social behaviors as 
compared to animals receiving vehicle (p=0.002). No significant differences were observed 
among groups for non-social behavior. 
2.4.3 Experiment 2b: 7, 8-DHF administered systemically reduces the 
consolidation of CD  
As shown in Figure 5, hamsters receiving a 10mg/kg IP injection of 7,8-DHF after defeat 
displayed a significant decrease in submissive and defensive behavior when tested 24 h later 
(Kruskal Wallis, p<0.05). No significant differences were observed for non-social, or social 
behavior. Aggression was not observed in any defeated animals. 
7, 8-DHF did not have an effect on behavior in no-defeat controls (Table 1; Kruskal 
Wallis, p>0.05). Furthermore, all defeated hamsters given vehicle showed a significant increase 
in submissive behavior as compared to the no-defeat, vehicle group (found in Table 1; Kruskal 
Wallis, p<0.05) indicating that exposure to social defeat resulted in CD as evidenced by a 
significant increase in the duration of submissive/defensive behavior following defeat.  
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2.4.4 Experiment 3: ANA-12 administered systemically increases the 
consolidation of CD 
As shown in Figure 6, hamsters receiving a 1mg/kg IP injection of ANA-12 after defeat 
displayed a significant increase in submissive and defensive behavior (Kruskal Wallis, p<0.05) 
when tested 24 h later. Administration of ANA-12 did not significantly alter social or non-social 
behavior in defeated hamsters. Aggression was not observed in any defeated animals. 
ANA-12 did not have an effect on behavior in no-defeat controls (Table 1; Kruskal Wallis, 
p>0.05). Furthermore, all defeated hamsters given vehicle showed a significant increase in 
submissive behavior as compared to the appropriate no-defeat, vehicle hamsters, (Table 1; 
Kruskal Wallis, p<0.05), indicating that exposure to social defeat resulted in conditioned defeat 
as evidenced by a significant increase in the duration of submissive/defensive behavior 
following defeat. 
 
2.5 Discussion 
Our current results were initially surprising to us, given that previous work from our lab 
and others had suggested that BDNF is necessary for fear learning and that BDNF mRNA 
increases in numerous brain regions following social defeat  (Rattiner et al., 2004; Taylor et al., 
2011; reviewed in Mahan & Ressler, 2012). Our current findings that a TrkB receptor agonist 
reduces submissive behavior and that a TrkB receptor antagonist enhances submissive behavior 
suggest instead that BDNF may act to prevent stress-induced changes in behavior and that this 
action occurs, at least in part, within the BLA.  
 Despite the results being initially surprising, they are consistent with an alternative 
hypothesis that BDNF promotes resiliency to stress (reviewed by Russo et al., 2012; Karatsoreos 
& McEwen, 2011) and that BDNF may underlie the therapeutic response to antidepressant 
treatment in depressed individuals (reviewed by Rothman and Mattson, 2013). Interestingly, 
BDNF is suppressed following exposure to stress in humans, and reduced BDNF protein in 
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serum is observed in patients with numerous psychiatric illnesses, as discussed above (Karege et 
al., 2002; reviewed by Duman and Monteggia, 2006; Castren & Rantamaki, 2010; Dell’osso et 
al., 2009; review by Rakofsky et al., 2012; Suliman, Hemmings, & Seedat, 2013; Dwivedi, 2010).  
Given the potential translational applications of BDNF as an antidepressant or a 
molecule that reduces the effects of stress and promotes resiliency, it is of particular interest to 
note that our peripheral injection of a TrkB receptor agonist produced a pro-resilient response 
(a decrease in the behavioral response to social stress), supporting the possibility that BDNF-
active drugs could be an effective treatment for those suffering from several psychopathologies, 
including PTSD and depression (Altar 1999, Duman 2004, Duman & Monteggia 2006). 
Theoretically, this work suggests that TrkB receptor agonists could be administered to humans 
immediately after a trauma occurs to prevent consolidation of information that promotes stress-
induced behavioral change. Our model of CD, therefore, provides us the opportunity to 1) 
determine potential translational effects of BDNF-active drugs via systemic injections following 
exposure to social stress and 2) to begin to identify where in the neural circuit these changes 
may be mediated specifically.  
Furthermore all findings in the current project, both site-specific and peripheral are 
consistent in that BDNF protects against the deleterious effects of stress as measured by a 
decrease in submissive behaviors. These findings were very surprising, given that k252a, a 
nonspecific Trk receptor antagonist, administered site-specifically into the BLA prior to defeat 
also decreased submissive behavior (Taylor et al., 2011). Although it was originally widely used 
and promoted as an acceptable TrkB receptor antagonist, k252a is now recognized to be a non-
specific Trk receptor antagonist that binds to both TrkA and TrkB receptors, as well as to a wide 
variety of other protein kinases (Arthur et al., 2005; Berg et al., 1992; Koizumi et al., 1988; 
Sofroniew et al., 2001). k252a is reported to act on numerous protein kinases, thus it is possible 
that this non-specific Trk antagonist is inhibiting down stream kinases involved in synaptic 
plasticity and LTM. This idea is of particular interest given that BDNF is reported to promote 
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and be critical for LTP, synaptogenesis, neural growth, and in addition have neuroprotective 
effects (Chao et al., 2006; Minichiello 2009; Autry & Monteggia, 2012; Gray et al., 2013). 
Interestingly, these neuroprotective effects are blocked by both chemical inhibitors of the ERK 
and PI3K pathways, and the protein synthesis inhibitor anisomycin (Almeida et al., 2005). As 
we have previously shown that anisomycin in the BLA reduces submission (Markham & 
Huhman, 2008), the aforementioned findings suggest that the k252a-induced reduction in CD 
may be mediated by an inhibition of synaptic plasticity in the BLA. In conclusion, additional 
studies will be necessary to determine the mechanism of action whereby k252a reduced 
submission as observed by Taylor and colleagues (2011). 
It is possible that BDNF interacted with gamma-amino butyric acid (GABA) to mediate 
the decrease in submission observed in the present study. Reductions in BDNF protein and 
mRNA are related to decreases in genes coding for GABA interneuron related peptides (e.g., 
somatostatin) in the amygdala of women suffering from major depressive disorder (Guilloux et 
al., 2012). In addition, GABA induces BDNF transcription in cortical cells (Fukuchi et al., 2014), 
and BDNF regulates maintenance and maturation of GABAergic synapses (Seil & Drake-
Baumann, 2000; Kuczewski et al., 2010) as well as the cellular localization of GABA receptors 
(Brunig et al., 2001; Elmariah et al., 2004; Wuchter et al., 2012). A dynamic interaction between 
BDNF and GABAergic systems is extremely interesting given that our lab has previously shown 
that administration of a GABA agonist, muscimol, blocks the acquisition and expression of CD 
(Jasnow et al., 2001) as measured by a decrease in submissive behaviors. The observed decrease 
in submission in both studies thus could be the result of the dynamic interaction between GABA 
and BDNF.  Finally, the interactions between BDNF and GABA appear to be nucleus-dependent 
(Brunig et al., 2001; Mou et al., 2011), something that should be considered in future studies 
given the variable effects of stress on GABA, BDNF, and neuronal plasticity in different nuclei. 
 The current findings combined with recent literature on BDNF lead us to 
speculate that BDNF may be a dynamic molecule that has differing effects depending on where 
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it is administered (reviewed in Sakata, 2013). Specifically, BDNF may promote stress responses 
when administered in some brain nuclei but reduce stress responses when administered into 
other nuclei. Given that we have established a putative neural circuit underlying CD, we 
maintain that this is an ideal model with which to explore the role of BDNF as a stress-reducing 
and stress-promoting molecule. Future studies should examine the effects of BDNF 
microinjections site-specifically into different nuclei within the putative CD circuit. While we 
predict that BDNF may have opposing effects in different component of a neural circuit, we 
must also be cognizant that BDNF in one nucleus likely interacts with and alters BDNF 
expression in other nuclei within the same circuit (Taliaz et al., 2013). This likelihood also 
underscores the importance of including peripheral manipulations, such as those used in this 
project, to determine what the overall sum of these different actions will be.   
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2.7 Figures  
 
Figure 2.1: Histological recreation of injection sites of animals receiving infusions in the BLA. Each symbol 
represents the injection site in one or more animals: Dots represent one or more hits and (triangles) represent 
misplaced injection sites. Drawings are adapted from Morin and Wood (2001). 
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Figure 2.2 Representative photomicrograph is shown of a coronal brain section of the BLA. The needle 
tract and ink injection are clearly visible. Injection volume (200 nl) of the ink was identical to the drug/vehicle 
volume used in Experiment 1. Abbreviations BLA-basolateral amygdala, Pir-piriform cortex, ot-optic tract.  
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Figure 2.3BDNF in the BLA reduces the acquisition of social defeat. Behaviors exhibited by previously 
defeated hamsters during a 5min test with an NAI are shown as percent of vehicle (+ standard error of the mean). 
Hamsters received a bilateral microinjection of rhBDNF or vehicle immediately prior to a 15 min social defeat with an 
RA. Symbols indicate differences for which p<0.05. * Indicates a significant difference (p<0.05) between defeated 
animals treated with rhBDNF or vehicle.  
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Figure 2.4 7,8-DHF reduces the acquisition of social defeat. Behaviors exhibited by previously defeated 
hamsters during a 5min test with an NAI are shown as percent of vehicle (+ standard error of the mean). Hamsters 
received an IP injection of 7,8-DHF or vehicle immediately prior to a 5 min social defeat with an RA. Symbols indicate 
differences for which p<0.05. * Indicates a significant difference (p<0.05) in submission between defeated animals 
treated with 10mg/kg rhBDNF or vehicle. ** Indicates a significant difference (p<0.05) in social behavior between 
between defeated animals treated with 2.5mg/kg rhBDNF or vehicle. # Indicates a significant difference (p<0.05) in 
social behavior between between defeated animals treated with 10mg/kg rhBDNF or vehicle. 
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Figure 2.5 7, 8-DHF reduces the consolidation of social defeat. Behaviors exhibited by previously defeated 
hamsters during a 5min test with an NAI are shown as percent of vehicle (+ standard error of the mean). Hamsters 
received an IP injection of 7, 8-DHF or vehicle immediately after a 5 min social defeat with an RA.  * Indicates a 
significant difference (p<0.05) between defeated animals treated with 7, 8-DHF or vehicle.  
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Figure 2.6 ANA-12 enhances the consolidation of social defeat. Behaviors exhibited by previously defeated 
hamsters during a 5min test with an NAI are shown as percent of vehicle (+ standard error of the mean).  Hamsters 
received an IP injection of ANA-12 or vehicle immediately after a 5 min social defeat with an RA. * Indicates a 
significant difference (p<0.05) between defeated animals treated with ANA-12 or vehicle.   
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Table 2.1 Mean Duration of Behavior (in sec) for No-Defeat animals in Consolidation Studies. 
Behavior	   	   Vehicle	   Drug	  
Submission	  
	  	  7,8-­‐DHF	  (10mg/kg)	  (TrkB	  agonist)	  	  	  
5.22	  +	  2.59	   1.36	  +1.00	  
	  	  ANA-­‐12	  (1.0mg/kg)	  (TrkB	  antagonist)	  	  	  	  
2.9+2.34	   10.22+7.40	  
Social	  
7,8-­‐DHF	  (10mg/kg)	  (TrkB	  agonist)	  	   204.30+20.50	   222.34+18.85	  
ANA-­‐12	  (1.0mg/kg)	  	  (TrkB	  antagonist)	   144.45+14.71	   128.51+15.88	  
Non-­‐Social	  
	  	  7,8-­‐DHF	  (10mg/kg)	  (TrkB	  agonist)	  	  	  	  
97.80+11.89	   87.33+12.20	  
	  ANA-­‐12	  (1.0mg/kg)	  	  (TrkB	  antagonist)	  	  	  
74.19+7.61	   79.15+11.43	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3  DOES 7,8-DIHYDROXYFLAVONE ALTER DEFEAT-INDUCED NEURAL 
ACTIVATION IN THE NEURAL CIRCUIT MEDIATING CONDITIONED DEFEAT  
3.1 Abstract 
Brain derived neurotrophic factor (BDNF) has numerous actions within the nervous 
system. This molecule promotes fear learning and is increased and decreased in a nucleus-
dependent fashion by stress. Our lab recently found that 7,8-dihydroxyflavone (7,8-DHF), a 
novel tyrosine kinase B (TrkB) receptor agonist, administered peripherally reduces submissive 
behavior in Syrian hamsters following social stress. It is not currently clear where in the brain 
this molecule is acting to alter the response to social stress. The aim of this project was to 
determine if 7,8-DHF alters defeat-induced neural activity in a nucleus-dependent fashion. 
Specifically, we measured social defeat-induced FOS-immunoreactivity (FOS-IR) as a proxy for 
neural activation in specific nodes of the neural circuit that mediates conditioned defeat and 
compared FOS-IR in animals administered 7,8-DHF to that observed following administration 
of vehicle or saline controls. A serious confound arose because 7,8-DHF must be dissolved in 
dimethyl-sulfoxide (DMSO), a solvent that has a variety of effects on both neurons and glia.  
Unfortunately, DMSO, alone, appears to induce FOS-IR in many of the nodes of the neural 
circuit mediating conditioned defeat as compared to vehicle controls. As a result, we are unable 
to address our original question. We were able to replicate previous work from our lab and 
others that defeat increases FOS-IR in the BLA and other nodes as compared to no defeat 
controls. We also found that 7,8-DHF reduces FOS-IR in the BLA and CeA as compared to the 
DMSO vehicle regardless of defeat experience. These data are discussed briefly. 
 
3.2 Introduction  
Brain derived neurotrophic factor (BDNF) has gained increasing attention for its role in 
stress responding, learning, and memory (Chao et al., 2006; Minichiello 2009). This protein 
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binds to tyrosine kinase receptors (TrkB) receptors in both brain and periphery and is known to 
be involved in neuron growth, plasticity, and synapse development (Chao et al., 2006; 
Minichiello, 2009). Therefore, it is not surprising that novel compounds have recently been 
developed to target TrkB, the cognate receptor for BDNF. 7, 8-dihydroxyflavone (7, 8-DHF), for 
example, is a novel TrkB receptor agonist that can be administered peripherally and that crosses 
the blood brain barrier (BBB) (Jang et al., 2010).  This route of administration provides a clear 
translational advantage, given that BDNF, itself, does not appear to cross the BBB (Pardridge, 
2007), which limits its efficacy when administered peripherally.  
7, 8-DHF administered peripherally in Syrian hamsters immediately after social defeat 
reduces submissive behaviors during subsequent testing 24h later (Jeffress et al., in 
preparation). As 7, 8-DHF administered peripherally prevents defeat-induced behavioral 
changes, the purpose of this project was to determine where in the brain 7, 8-DHF may be 
regulating these changes. We recently found that BDNF administered into the basolateral 
amygdala (BLA) reduces submissive behavior (Jeffress et al., in preparation), suggesting that 
BDNF promotes resiliency to stress and that this behavioral change is mediated, at least in part, 
by the BLA.  BDNF in the BLA is of particular interest given that this nucleus is necessary for the 
dramatic behavioral change after social defeat known as conditioned defeat (CD) (Jasnow, 
2005; Markham et al., 2010). 
Recent work on BDNF and social stress has generated controversy as to whether BDNF 
promotes or prevents behavioral responses to stress.  It has recently been suggested that the 
effects of this molecule depend upon where in a neural circuit BDNF is examined because BDNF 
may site-specifically increase or decrease with stress exposure and the behavioral output is 
going to reflect the net activity of the overall circuit  (reviewed in Sakata, 2013). Repeated social 
defeat stress, for example, decreases BDNF protein in the amygdala of rats (Fanous et al., 2010), 
whereas repeated social stress in mice increases BDNF protein in the amygdala (reviewed by 
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Boyle, 2013). Given such conflicting literature about BDNF in the amygdala, it is not surprising 
that several labs continue to examine this protein in models of stress and fear learning. 
The BLA is of particular interest for our lab because this nucleus plays a central role in 
the putative neural circuit of CD (Figure 1). The BLA is necessary for both the acquisition and 
expression of CD (Jasnow, 2005; Markham et al., 2010; Day et al., 2011), and synaptic plasticity 
in the BLA is required for CD learning (Jasnow, 2005; Markham et al., 2010).  Beyond CD, the 
BLA has a clear and critical role in fear learning (reviewed in Martijena & Molina, 2012; 
Roozendaal, McEwen & Chattarji, 2009; McGaugh, 2000), and changes in neuronal activation 
are found in the BLA following stress. For example, the expression of the immediate early gene 
product FOS increases in the BLA following social defeat in Syrian hamsters (Markham et al., 
2010) and in mice (Bourne et al., 2013; Nikulina et al., 2008), indicating that defeat stress 
induces neural activity in the BLA.  Chronic stress also increases spine density and dendritic 
growth in the BLA (reviewed by Roozendaal, McEwen & Chattarji, 2009). Because activation of 
the BLA is critical for CD it seems likely that a molecule that promotes resiliency to social stress 
such as BDNF may act in the BLA to reduce defeat-induced neural activation.  
It is also possible that activation of the BLA in response to social defeat is modulated by 
numerous other nodes within the circuit mediating conditioned defeat such as the medial 
prefrontal cortex (mPFC).  The mPFC in rodents is composed of the prelimbic cortex (PL) and 
the infralimbic cortex (IL) (Milad et al., 2007; Myers-Schulz & Koenigs, 2012; Quirk & Beer, 
2006; Slattery, Neumann, & Cryan, 2011). We have previously reported that the mPFC is 
necessary for the acquisition of CD (Markham et al., 2012), yet this brain region is also known to 
promote resiliency (Bader et al., 2014; Amat et al., 2014). Therefore, it is possible that BDNF 
reduces CD by promoting activation of the mPFC which in turn suppresses neural activity in the 
BLA.  
The goal of the project was to determine where within the brain a peripherally 
administered TrkB receptor agonist might act to reduce the behavioral response to social defeat.  
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FOS-immunoreactivity (FOS-IR) was used as an indirect marker of neural activation to 
determine which brain nuclei might be involved.  Specifically, FOS-IR in the PL, IL, CeA, BLA, 
medial amygdala (MeA), and the caudate putamen (CPu) were examined. We predicted that 
systemic 7, 8-DHF would reduce FOS-IR in the BLA and possibly other nodes within the 
conditioned defeat circuit.  
 
3.3 Methods & Materials  
3.3.1 Animals and Housing Conditions 
Thirty-one male Syrian hamsters (Mesocricetus auratus, Charles River Laboratories, 
New York, NY) that weighed 120-140 g, and were between 9-10 weeks old at the time of testing, 
were used in this experiment. Upon arrival, animals were individually housed for one week prior 
to any manipulation (quarantine measure), and all hamsters were handled for five days prior to 
behavioral procedures to acclimate them to experimenter handling. Hamsters were housed in 
polycarbonate cages (20x 40 x 20cm) with corncob bedding and wire mesh tops in a 
temperature (20 ± 2° C) and humidity-controlled room. The room was maintained on 14:10 
light/dark cycle with lights off at 10:00 h. Food and water were available ad libitum. Older 
hamsters (>6 months) individually housed (>1 month) weighing at least 180g served as resident 
aggressors (RA) in defeat training for all experiments. All procedures and protocols were 
approved by the Georgia State University Institutional Animal Care and Use Committee and are 
in accordance with the standards outlined in the National Institutes of Health Guide for Care 
and Use of Laboratory Animals. 
3.3.2 Social Defeat  
Prior to training, hamsters were weight-matched and randomly assigned to groups. All 
animals were transported in their home cage to the behavioral testing suite within the animal 
vivarium 30 mins prior to all behavioral manipulations. All behavioral procedures were 
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performed in the first 3 h of the light dark cycle to minimize any circadian effects. Social defeat 
training occurred in the home cage of the RA for 15 min. No-defeat animals were placed into an 
empty RA cage for 15 min to expose animals to odors but no physical interaction. 
3.3.3  Drug Administration 
Animals received a 10mg/kg intraperitoneal (IP) injection of the TrkB receptor agonist, 
7,8-DHF, dissolved in 40% Dimethylsulfoxide (DMSO) and 60% saline (TCI America; 
Montgomeryville, PA), the respective vehicle (40% DMSO/60% saline), or 100% physiological 
saline immediately after defeat. This dosage of 7,8-DHF has been used previously and was found 
to significantly reduce CD. We chose to add a group of animals receiving a saline control 
treatment as a positive control for our drug vehicle (40% DMSO/60% saline) given that DMSO 
is reported to have several wide-reaching and negative effects on cells that are often ignored 
(reviewed by Santos et al., 2003).  
3.3.4 Immunohistochemistry 
Animals were administered an anesthetizing dose of sodium pentobarbital 60 min after 
the peripheral injection. Subjects were then perfused transcardially with 0.1 M potassium 
phosphate-buffered saline (KPBS) followed by 4% paraformaldehyde. Brains were post-fixed in 
4% paraformaldehyde overnight and switched to a 30% sucrose-paraformaldehyde solution and 
kept at 4°C for an additional 48 h. Brains were blocked on the coronal plane and sectioned on a 
cryostat to a thickness of 30 um. Consecutive sections were placed sequentially across 4 wells 
filled with cryoprotectant. The sections included the PL and the IL, and continued through the 
BLA. Sections were labeled for FOS using primary antisera directed against the protein product 
of the immediate early gene c-fos (rabbit anti-c-fos polyclonal antibody, 1:10,000; Santa Cruz 
Biotechnology). 
All washes, rinses, and incubations were performed in 25-well tissue culture plates, 
which were gently shaken on an orbital shaker throughout the procedure. Sections were rinsed 
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in 0.1 M KPBS and incubated in a 0.3% hydrogen peroxide solution for 15 min, followed by a 
KPBS wash. Sections were then incubated for 18 h in the primary antibody at room temperature 
in 1% solution of Triton X-100 in 0.1 M KPBS (1% KPBS-T) with normal goat serum (NGS). 
Following incubation with the primary antibody, the sections were rinsed in KPBS and 
incubated for 90 min at room temperature in 1% KPBS-T containing the secondary antibody 
(biotintylated horse anti-rabbit IgG polyclonal antibody, 1:200; Jackson ImmunoResearch). 
They were then rinsed with KPBS, followed by incubation for 1 h with an avidinbiotin complex 
reagent (Vectastain Elite ABC kit: Vector Laboratories). After rinsing with KPBS, sections were 
incubated in nickel-3, 39-diaminobenzidene (DAB) Kit (Vector) for 2-4 min in order to produce 
a blue-black-stained product and then washed again in KPBS in order to halt the DAB reaction. 
Finally, sections were mounted on gelatin-coated slides, dehydrated, and cover slipped with 
DPX (VWR International). 
3.3.5 Cell Counting 
An observer blind to the treatment conditions performed all cell counts using bright field 
microscopy at 10X magnification. For the quantification of FOS-IR labeling, areas of interest 
were first delineated using adjoining Neutral Red-stained sections. FOS-labeled cells were 
photographed using a Zeiss Camera (Jena, Germany) within the region of interest established by 
the Neutral Red templates. Cells were counted using Image J Software (NIH) in the PL, IL, CeA, 
BLA, MeA, and the CPu. Threshold levels were set, background levels were controlled, and cells 
were counted by this program within a computer-generated template placed over the region of 
interest on each photograph. See Figure 2, for a representative photomicrograph.  
3.3.6 Statistical Methods 
Independent samples t-tests were used to compare saline-defeat and saline-no defeat in 
regions of interest. 2x2 ANOVAs were used to compare the effects of defeat (defeat or no defeat) 
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and drug (7,8-DHF or 40%DMSo/60%DMSO) on FOS-IR in each region of interest. Analyses 
were performed with IBM SPSS software (20.0.0). Criterion for significance was p<0.05. 
3.4 Results  
3.4.1 Basolateral amygdala  
Animals that received IP saline immediately after a 15 min defeat (n=7) demonstrated a 
significant increase in FOS-IR in the BLA as compared to animals that received saline but were 
not exposed to defeat (n=3) (t (8)=2.77, p<0.05) (see Figure 3). 
IP administration of 7,8-DHF reduced the expression of FOS-IR in the BLA of hamsters 
(n=11) as compared to FOS-IR in the BLA of hamsters (n=10) that received an IP injection of 
vehicle (40% DMSO/ 60% saline) (F (1)=4.912, p<0.05) (see Figure 4). No main effect of defeat 
and no defeat x drug interaction was found in the BLA. 
3.4.2 Central Amygdala  
Animals that received IP saline immediately after a 15 min defeat (n=7) appeared to 
demonstrate an increase in FOS-IR in the CeA as compared to animals that received saline but 
were not exposed to defeat (n=3).  This apparent increase was not significant, but there was a 
strong trend to suggest that defeat enhances FOS-IR in this nucleus (t (8) =-2.191, p=0.06) 
(Figure 3). 
IP administration of 7,8-DHF reduced the expression of FOS-IR in the CeA of hamsters 
(n=11) as compared to FOS-IR in the CeA of hamsters (n=10) that received an IP injection of 
vehicle (40% DMSO/60% saline) (F (1)=8.462, p<0.05) (Figure 5). No main effect of defeat and 
no interaction was found. 
 
3.4.3 Medial Amygdala 
FOS-IR was examined in the MeA of animals that received saline immediately after a 15 
min defeat (n=7) or after 15 min of no defeat (n=3). There were no differences among groups in 
this nucleus (t (8) =-1.184, p>0.05) (see Figure 3). 
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No main effect of defeat (F (1,17)=0.730,p>0.05) or drug (F (1,17)=0.678,p>0.05) was 
found in the MeA, and there was no drug x defeat interaction (F (1,17)=0.012,p>0.05)  (see 
Figure 6). 
 
3.4.4  Prelimbic Cortex  
FOS-IR was examined in the PL of animals that had received saline immediately after a 
15 min defeat (n=7) or after 15 min of no defeat (n=3). There were no differences in this nucleus 
(t (8) =0.490, p>0.05) (see Figure 3).  
No main effect of defeat (F (1,17)=0.316,p>0.05) or drug (F (1,17)=0.722,p>0.05) was 
found in the PL. There was also no interaction in this nucleus (F (1,17)=2.135,p>0.05)  (see 
Figure 7). 
3.4.5 Infralimbic Cortex  
FOS-IR was examined in the IL of animals that had received saline immediately after a 
15 min defeat (n=7) or after 15 min of no defeat (n=3). There were no differences in this nucleus 
(t (8) =0. -570, p>0.05) (see Figure 3). 
No main effect of defeat (F (1,17)=0.054,p>0.05) or drug (F (1,17)=0.050, p>0.05) was 
found in the IL, and there was no drug x defeat interaction (F (1,17)=2.962, p>0.05) (see Figure 
7). 
3.4.6 Caudate Putamen 
In order to ensure that 7,8-DHF or the vehicle (40%DMSO/60%saline), alone, did not 
cause global changes in neural activity throughout the brain, FOS-positive cells were also 
counted in the CPu, a brain region that is near both the mPFC and the amygdala, but that is not 
included in the putative neural circuit controlling CD.  
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FOS-IR was examined in the CPu of animals that had received saline immediately after a 
15 min defeat (n=7) or after 15 min of no defeat (n=3). There were no differences in this nucleus 
(t (8) =0.676, p>0.05) (Figure 3). 
 
No main effect of defeat (F (1,17)=0.837,p>0.05) or drug (F (1,17)=0.276,p>0.05) was 
found in the CPu. There was also no interaction in this nucleus (F (1,17)=0.029,p>0.05) (see 
Figure 8). 
 
3.5 Discussion 
Unfortunately, the current project did not produce interpretable data due to the distinct 
FOS response that resulted from the vehicle injection.  As a result of this confound, we were 
prevented from addressing our original hypothesis.  There are, nonetheless, some important 
points that can be gleaned from this work.  First, our findings strongly suggest that using a 40% 
DMSO/60% saline vehicle is contraindicated, as this mixture independently enhances neural 
activation as measured by FOS-IR in some brain nuclei regardless of defeat experience. 
Fortuitously, we had included a separate group of animals that received only saline injections 
because there have been sparse reports that DMSO is not an ideal solvent for pharmacological 
manipulations (Santos et al., 2003).  These saline-treated animals also served as a positive 
control wherein we were able to demonstrate that exposure to social defeat stimulates FOS-IR in 
the BLA, a finding that our lab and others had reported previously (Bourne et al., 2013; Nikulina 
et al., 2008; Markham et al., 2010).  
We also found a strong trend suggesting that defeat increases FOS-IR in the CeA.  A 
similar pattern was observed in the MeA and the IL.  The statistical power in the current study 
was limited due to the small group size in the saline-defeat condition and to the unequal group 
numbers in defeat and no-defeat conditions. Previous studies have found that 15 min defeats 
increased fos mRNA in the CeA of defeated hamsters as compared to handled controls (Kollack-
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Walker et al., 1997; Kollack-Walker et al., 1999), so it is likely that increasing our group numbers 
would move this trend to statistical significance. Because demonstrating this difference was not 
the aim of this study, however, we elected not to use additional animals for this purpose. 
Similarly, we did not observe significant changes in FOS-IR the MeA possibly again because of 
statistical reasons (i.e., sample size) as increases in c-fos mRNA in the MeA have been reported 
previously in fighting hamsters as compared to handled controls (Kollack-Walker et al., 1997). 
We were somewhat surprised that defeat did not significantly alter FOS-IR in the PL, 
and IL given that others have reported neural activation in these 2 brain areas. For example, 
repeated social defeat stress increases delta Fos B expression in the IL and the PL (Nikulina et 
al., 2012), and Morrison and colleagues also reported that FOS-IR is increased in the IL of 
dominant as compared to subordinate Syrian hamsters (Morrison et al., 2012). Our failure to 
demonstrate a change in FOS-IR could be due to the fact that 1) our animals were not subjected 
to repeated defeat, and 2) we were not comparing dominant and subordinate animals. 
 As expected, we did not observe changes in FOS-IR in the CPu. The CPu was selected to 
serve as a control nucleus near our regions of interest to ensure that 7,8-DHF and the vehicle 
were not inducing global neural activity. The finding that there were no changes in FOS-IR in 
the CPu further supports the contention that the changes in neural activation observed were 
nucleus specific. 
Unfortunately, to date, all commercially available compounds that bind specifically to 
TrkB receptors are not soluble in physiological saline but must be dissolved in vehicles such as 
DMSO.  DMSO is an extremely effective solvent that is widely used in behavioral 
pharmacological studies, but it has some important limitations that are largely overlooked.  For 
example, 0.2% DMSO is reported to induce c-fos mRNA in cell culture in Northern analysis 
(Stewart, Herrrera, & Nordheim, 1990). DMSO also decreases cell viability of hippocampal cells 
in culture (Lu & Mattson, 2001), increases EPSP amplitudes in NMDA and non-NMDA 
receptors (Tsvyetynska et al., 2005), induces apoptosis in the developing CNS (P0-P30) 
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(Hanslick et al., 2009), and inhibits glutamate activity in hippocampal neurons (Lu & Mattson, 
2001).  
In our study, DMSO appeared to have very variable effects on FOS-IR within the 
different nuclei within the conditioned defeat neural circuit, rendering the data largely 
uninterrpretable.  7, 8-DHF, however, significantly reduces the DMSO-induced increase in FOS-
IR seen in the BLA and CeA. We are uncertain as to why TrkB receptor agonism reduces DMSO-
induced FOS-IR, and we can only speculate on why this occurred. A possible explanation is that 
BDNF is purported to have a restorative effect, given that it is known to reduce apoptosis, stress, 
and inflammation (see Duman, 2009 for review). Thus, the TrkB receptor agonist might have 
had these same effects within the BLA and CeA, which then reduced the DMSO-induced cellular 
activation. Despite our findings that DMSO alters FOS-IR, we have separately tested whether 
DMSO, alone, alters behavior in agonistic interactions and have shown that it does not (data not 
shown).  
In summary, the current findings are largely uninterpretable because of the unfortunate 
effect of the DMSO vehicle on FOS-IR in both the BLA and the CeA. These findings highlight the 
importance of positive controls such as saline controls in experimental design and also 
underline the importance of developing novel compounds that are readily soluble in 
physiological saline or other vehicles that do not have biobehavioral effects. 
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3.7 Figures  
 
Figure 3.1. Putative Circuit Mediating the Acquisition and Expression of Conditioned Defeat 
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Figure 3.2. Representative photomicrograph (10X magnification) of defeat-induced Fos-IR in the BLA in 
saline no defeat (A) and saline defeat (B). (outlined in red). Black dots indicate FOS immunopositive nuclei. Sample 
photomicrograph and the adjoining drawing of the BLA are approximately 1.2 mm posterior to bregma (adapted from 
Morin & Wood, 2001). 
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Figure 3.3. Defeat and FOS-IR in saline controls. Defeat significantly enhances FOS-IR in the BLA. A 
strong trend (p=0.06) is also observed in the CeA. Defeat, however, does not significantly alter FOS-IR in the 
additional nuclei within our putative CD circuit including the MeA, the PL, or the IL. * indicates a significant 
difference (p<0.05) between FOS-IR in the BLA of defeat and no defeat groups. 
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Figure 3.4. 7,-8DHF decreases vehicle induced FOS-IR in the BLA. 7,8-DHF significantly reduces vehicle 
induced FOS-IR in the BLA as compared to hamsters treated with vehicle (40% DMSO/ 60% saline) regardless of 
defeat experience (defeat or no defeat). There is no main effect of defeat on FOS-IR and no significant interactions 
between drug x defeat on FOS-IR were found in the BLA.* indicates a significant difference (p<0.05) between FOS-IR 
in the BLA of animals treated with  7,8-DHF or vehicle (40% DMSO/60% Saline). 
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Figure 3.5. 7,-8DHF decreases vehicle induced FOS-IR in the CeA. 7,8-DHF significantly reduces vehicle 
induced FOS-IR in the CeA as compared to hamsters treated with vehicle (40% DMSO/ 60% saline) regardless of 
defeat experience (defeat or no defeat). There is no main effect of defeat on FOS-IR and no significant interactions 
between drug x defeat on FOS-IR were found in the CeA.* indicates a significant difference (p<0.05) between FOS-IR 
in the CeA of animals treated with  7,8-DHF or vehicle (40% DMSO/60% Saline). 
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Figure 3.6 . No significant differences in FOS-IR were found in the MeA. No main effects of defeat or drug 
were found in the MeA. There are also no interactions between defeat x drug.  
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Figure 3.7 .  No significant differences in FOS-IR were found in the mPFC (PL or IL). No main effects of 
defeat or drug were found in the mPFC (PL or IL). There are also no interactions between defeat x drug.   
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Figure 3.8 . No significant differences in FOS-IR were found in the CPu. The CPu was selected as control 
nucleus outside of the putative CD circuit. No main effects of defeat or drug were found in the CPu. There are also no 
interactions between defeat x drug. FOS-IR is highly variable within this nucleus across the groups. 
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4 BDNF IN THE MEDIAL PREFRONTAL CORTEX ALTERS DEFEAT INDUCED 
NEURAL ACTIVITY IN SYRIAN HAMSTERS  
4.1 Abstract 
Brain derived neurotrophic factor (BDNF) has numerous actions within the nervous 
system. This molecule, which binds to the tyrosine kinase B (TrkB) receptor, is necessary for fear 
learning and alters behavioral responses to stress. It appears that BDNF may increase in some 
brain nuclei and decrease in others following exposure to stress. Our lab has recently 
demonstrated that 7,8-dihydroxyflavone (7,8-DHF), a novel TrkB receptor agonist, 
administered peripherally reduces submissive behaviors in Syrian hamsters following social 
stress, a finding which suggests that BDNF may have stress-reducing or resilience-promoting 
effects. This work, however, did not identify where in the brain BDNF might act to alter the 
response to social defeat stress. One circuit of interest in terms of stress responding and 
resilience is the medial prefrontal cortex (mPFC), which is reciprocally connected with the 
basolateral amygdala (BLA), the key site of plasticity in conditioned defeat (CD). Interestingly, 
disruption of this circuit is associated with neuropsychiatric disorders including posttraumatic 
stress disorder (PTSD). This project was designed to test the hypothesis that BDNF alters 
defeat-induced neural activation in the BLA at least in part by acting within the mPFC.  
Interestingly, we found that BDNF microinjected site-specifically into the mPFC after social 
defeat increases defeat-induced neural activation of the BLA, as measured via expression FOS-
immunoreactivity (FOS-IR). These results suggest that BDNF may alter social stress-induced 
behavioral responses at least in part by acting in the mPFC, which in turn modulates neural 
activity in the BLA. 
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4.2 Introduction  
Stress is a critical factor that places individuals at an increased risk for developing 
neuropsychiatric disorders (Sapolsky, 2000; Karatsoreos & McEwen, 2011) including depression 
and posttraumatic stress disorder (PTSD) (Gilbert & Allan 1998; Heim & Nemeroff 2001; 
McEwen & Stellar 1993;Pêgo et al., 2010; Shin & Liberzon, 2010). The amygdala and the medial 
prefrontal cortex (mPFC) are altered by stress and modulate fear memory and stress responding 
(reviewed by Roozendaal, McEwen & Chattarji, 2009).  It is therefore not be surprising that 
these same projections between the amygdala and the mPFC appear to have a role in 
neuropsychiatric illnesses such as PTSD and depression. Specifically, disease states such as 
PTSD and depression are often characterized by an over-active amygdala and decreased 
inhibitory control of the amygdala by the mPFC (Rabinak et al., 2014; Rive et al., 2013; Erk et 
al., 2010; Hamilton et al., 2008; Jovanovic et al., 2013).   
In addition, work in animal models has demonstrated that reciprocal projections 
between the amygdala and the mPFC are involved in fear learning and in threat identification 
(Ishikawa & Nakamura 2003; Marek et al., 2013; Ongur & Price 2000). The mPFC is composed 
of the infralimbic cortex (IL) and the prelimbic cortex (PL) in rodents, which is analogous to 
Brodmann’s Area (BA) 25 and BA 32, respectively, in humans (Milad et al., 2007; Myers-Schulz 
& Koenigs, 2012; Quirk & Beer, 2006; Slattery, Neumann, & Cryan, 2011). Tract tracing studies 
in animals have found that the IL and the PL send projections to sub-nuclei within the 
amygdala, including the basolateral amygdala (BLA) and the central amygdala (CeA) (Vertes, 
2004; Gabbott, 2005). These 2 sub-nuclei in the mPFC appear to act in opposition, given that 
stimulation of the PL enhances freezing (Vidal-Gonzalez et al., 2006), whereas stimulation of 
the IL decreases freezing (Milad & Quirk, 2002; Milad et al., 2004). Accordingly, the PL is 
necessary in fear acquisition and expression, whereas the IL is necessary for fear extinction 
(Sierra-Mercado et al., 2011). It has previously been suggested that the projections from the PL 
to the BLA are excitatory, which in turn would increase activity of the BLA and could result in 
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excitation of the CeA and downstream symptoms of fear and anxiety (i.e., increase stress-
induced freezing) (Vidal-Gonzalez et al., 2006; Sierra-Mercado et al., 2011). In contrast, 
projections of the IL synapse on the intercalated cells, clusters of GABAergic neurons that exert 
feed-forward inhibition of the CeA, resulting in reduced freezing behavior (Vidal-Gonzalez et al., 
2006; Sierra-Mercado et al., 2011). Overall, the preponderance of evidence suggests that the PL 
and IL have opposite effects on the amygdala and that dysregulation of either might play a role 
in a variety of neuropsychiatric disorders.  
The PL and IL, not surprisingly, display altered neuronal activity following exposure to 
stress. Specifically, both the PL and IL are active following stress, as measured by immediate 
early genes. Repeated social defeat, for example, increases delta FOS B, a truncated splice 
variant of FosB, in the IL and PL (Nikulina et al., 2012). Studies examining the IL and PL 
individually have found region-specific differences in neural activation. Morrison and colleagues 
found that FOS-immunoreactivity (FOS-IR) is increased in the IL of dominant as compared to 
subordinate Syrian hamsters (Morrison et al., 2012). Muscimol administered site-specifically in 
the IL of dominant hamsters increases CD (Morrison et al., 2013), suggesting that the IL is 
important for resistance to a social defeat stressor. Similarly, lesions of the IL eliminate the 
stress-reducing effects of enriched housing environments on social defeat in mice (Lehmann 
and Herkenham, 2011). Furthermore, recent work suggests that the PL underlies susceptibility 
to social defeat. Specifically, over expression of delta FOS B in the PL and infusion of a 
cholecystokinin (CCK) agonist into the PL promotes depression-like and anxiety-like behaviors 
after social defeat (Vialou et al., 2014). These studies suggest that both the PL and the IL are 
differentially altered by stress and that they may play opposite roles in modulating brain regions 
that control behavioral responses to stress. 
Stress also alters BDNF expression in the mPFC. BDNF mRNA in both the PL and IL 
increase immediately following inescapable stress in rats (Bland et al., 2005), suggesting that 
BDNF is involved in stress-induced changes in both of these nuclei. Site-specific changes in 
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BDNF expression is of particular interest given that BDNF is altered by stress in the neural 
circuit implicated in PTSD (e.g., the mPFC and the amygdala). Interestingly, recent work using 
BDNF knockout mice has found that BDNF in the PL is necessary for the consolidation of fear 
learning (Choi et al., 2010; Choi et al., 2012), whereas BDNF in the IL is necessary for extinction 
of fear (Peters et al., 2010).  This finding provides additional evidence that these 2 nuclei act in 
opposition and that BDNF may also play an important role in this process.  
One animal model that may help to shed light on the role that BDNF plays in the PL and 
IL is conditioned defeat (CD), a dramatic behavioral change that occurs following exposure to a 
brief social defeat stressor (Potegal et al., 1993; Huhman et al., 1990; Huhman et al., 1991a; 
Huhman et al., 1991b; Huhman et al., 1992; Huhman et al., 2003). The putative neural circuit 
that underlies CD in hamsters has been characterized (Markham & Huhman, 2008; Markham et 
al., 2009; Markham et al., 2010; McDonald et al., 2012), and the BLA and the mPFC have been 
shown to modulate the acquisition and/or expression of CD (Jasnow, 2005; Markham et al., 
2010; Day et al., 2011; Markham et al., 2012). We have recently demonstrated that BDNF 
administered peripherally or site-specifically into the BLA reduces CD (Jeffress et al., in 
preparation); however, it is unclear if the BLA is the only nuclei wherein BDNF acts to alter 
neuronal activity and in turn mediate behavioral output. Given that the BLA and the mPFC are 
reciprocally connected and are both altered by stress, and that BDNF within in these nuclei is 
involved in conditioned learning, it seems reasonable to propose that BDNF may act to 
modulate CD at least in part via its actions in the mPFC. Thus, this project was designed to gain 
a better understanding of the circuitry underlying CD and the role of BDNF within that circuit. 
We expected that BDNF administered into the PL would enhance defeat-induced FOS-IR in the 
BLA and CeA, whereas BDNF administered into the IL would suppress defeat-induced FOS-IR 
in the BLA and CeA. The predictions are illustrated in Figure 1 (adapted from Vidal-Gonzalez et 
al., 2006; Sierra-Mercado et al., 2011), 
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4.3 Methods & Materials 
4.3.1 Animals and Housing Conditions 
Subjects in all experiments were male Syrian hamsters (Mesocricetus auratus, Charles 
River Laboratories, New York, NY) that weighed 120-140 g and were between 9-10 weeks old at 
the time of testing. Upon arrival, animals were group housed with 5-6 animals per cage for one 
week prior to any manipulation (quarantine measure). All hamsters were handled for five days 
prior to behavioral procedures to acclimate them to experimenter handling, and singly housed 
in polycarbonate cages (20x 40 x 20cm) with corncob bedding and wire mesh tops in a 
temperature (20 ± 2° C) and humidity controlled room. The room was maintained on 14:10 light 
dark cycle with lights off at 10:00 h. Food and water were available ad libitum. Older hamsters 
(>6 months) individually housed (>1 month) weighing at least 180g served as resident 
aggressors (RA) in defeat training. All procedures and protocols were approved by the Georgia 
State University Institutional Animal Care and Use Committee and are in accordance with the 
standards outlined in the National Institutes of Health Guide for Care and Use of Laboratory 
Animals.  
4.3.2 Surgical Procedures  
Subjects were deeply anesthetized for the duration of the surgery (3.75% isoflurane at a 
flow rate of 1 lpm), and breathing and body temperature were monitored while animals were 
under anesthesia. A unilateral stainless steel guide cannula (26-gauge, Plastics One, Roanoke, 
VA) was stereotaxically implanted at a 20° angle toward the midline in either the left or right 
hemisphere (0.2mm posterior and ±3.2mm lateral to bregma and 2.2 mm below dura for IL; 
0.2mm posterior and ±2.9mm lateral to bregma and 1.9 mm below dura for PL). Following 
surgery, dummy stylets were placed in the guide cannula to help maintain patency and 1 cc of 
physiological saline and 0.1 cc of ketoprofen were injected subcutaneously in order to aid in 
recovery. In order to minimize tissue damage to the area of interest, a smaller, 33-gauge 
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injection needle (Plastics One, Roanoke, VA) that projected 1.2 mm below the guide cannula was 
used on injection day in order to reach a final depth of 3.1 or 3.4 mm below dura.  Prior to 
behavioral testing, hamsters were monitored daily to ensure that there were no adverse 
outcomes from the surgery. Hamsters were allowed 5 days to recover.  
4.3.3 Social Defeat  
The CD model has been described in detail elsewhere (Huhman et al., 2003). Prior to 
training, hamsters were weight matched and randomly assigned to groups. All animals were 
transported in their home cage to the behavioral testing suite within the animal vivarium 30 min 
prior to all behavioral manipulations in order to acclimate. All behavioral procedures were 
performed in the first 3 h of the light dark cycle to minimize any circadian effects. Social defeat 
training occurred in the home cage of the RA for 15 min. No animals were injured during 
training. No-defeat animals were placed into an empty RA homecage for 15 min to expose 
animals to odors but no physical interaction. 
 
4.3.4  Drug Administration 
Animals received a unilateral infusion of rhBDNF (Sigma; St. Louis, MO) into the PL or 
IL. Animals (n=45) were randomly assigned to groups (defeat or no defeat) and within these 2 
conditions; animals received either 0.4ng/50nL rhBDNF in physiological saline or vehicle 
(saline).  The very small injection volume (50nL) was selected to attempt to limit diffusion of the 
microinjection of rhBDNF between adjacent nuclei (i.e., PL and IL).  Dosages were selected 
based on previous work using site-specific microinjections of rhBDNF in rats in the 
periaqueductal grey  (Casarotto et al., 2010). All injections were administered immediately 
following a 15 min defeat or a no-defeat control exposure to the RA cage. 
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4.3.5 Site Verification & Immunohistochemistry  
Sixty minutes after the behavioral manipulation and microinjection, all experimental 
animals received an overdose of sodium pentobarbital and were unilaterally infused with 50nl of 
India ink to verify needle placement. Subjects were then perfused transcardially with 0.1 M 
potassium phosphate-buffered saline (KPBS) and 4% paraformaldehyde. Brains were post-fixed 
in 4% paraformaldehyde overnight and switched to a 30% sucrose-paraformaldehyde solution 
and kept at 4°C for an additional 48 h. Brains were blocked on the coronal plane and sectioned 
on a cryostat (Leica CM 3050 S) to a thickness of 30 um. Consecutive sections were placed 
sequentially across 4 wells filled with cyroprotectant. The sections covered the BLA in its 
entirety. One series of sections containing the PL and the IL were collected and then stained 
with Neutral red; cover slipped with Permount mountant (Fisher), and then examined using a 
light microscope for ink in the PL/IL. Only brains with a clear unilateral ink injection within 
0.3mm of the PL or the IL was included in the final analysis as determined by 2 blind observers. 
Injections that were outside of the PL or IL (i.e., greater than 0.3mm) or that had ink diffusion 
within both the IL and PL were analyzed separately as an anatomical miss control group and 
injections that did not result in visible ink were excluded from analysis. 
Sections were labeled for FOS using primary antisera directed against the protein 
product of the immediate early gene c-fos (rabbit anti-c-fos polyclonal antibody, 1:10000; Santa 
Cruz Biotechnology). All washes, rinses, and incubations were performed in 25-well tissue 
culture plates, which were gently shaken on an orbital shaker throughout the procedure. 
Sections were rinsed in 0.1 M KPBS and incubated in a 0.3% hydrogen peroxide solution for 15 
min, followed by a KPBS wash. Sections were then incubated for 18 h in the primary antibody at 
room temperature in 1% solution of Triton X-100 in 0.1 M KPBS (1% KPBS-T) with normal goat 
serum (NGS). Following incubation with the primary antibody, the sections were rinsed in KPBS 
and incubated for 90 min at room temperature in 1% KPBS-T containing the secondary antibody 
(biotintylated horse anti-rabbit IgG polyclonal antibody, 1:200; Jackson ImmunoResearch). 
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They were then rinsed with KPBS, followed by incubation for 1 h with an avidinbiotin complex 
reagent (Vectastain Elite ABC kit: Vector Laboratories). After rinsing with KPBS, sections were 
incubated in nickel-3, 39-diaminobenzidene (DAB) Kit (Vector) for 2-4 min in order to produce 
a blue-black-stained product and then washed again in KPBS in order to halt the DAB reaction. 
Finally, sections were mounted on gelatin-coated slides, dehydrated, and cover slipped with 
Permount (Fisher). 
4.3.6 Cell Counting 
Two observers that were blind to the treatment conditions performed all cell counts by 
hand using bright field microscopy at 10X magnification. For the quantification of FOS-IR 
labeling, areas of interest were first delineated using adjoining Neutral Red stained sections. 
FOS-labeled cells were photographed using a Zeiss Camera (Jena, Germany) within the region 
of interest established by the templates determined from nissl-stained alternate sections. 
4.3.7 Statistical Methods 
FOS values were expressed as mean ± SEM. A 2x2 ANOVA was used to compare the 
effects of defeat and drug on FOS-IR when data did not violate assumptions. Non-parametric 
tests (Kruskal-Wallis using Mann Whitney U for post-hoc analysis) were used when  our 
behavioral data violated assumptions of homogeneity (Levene’s Test, P>0.05) or normality 
(examined using the Kolmogorov Smirnov test),  Analyses were performed with IBM SPSS 
software (20.0.0). Criterion for significance was set to p<0.05.  
  
  
4.4 Results  
Statistical analysis revealed that there were no differences between injections in the PL 
and the IL (Table 1), thus data from PL and the IL injections were collapsed for statistical 
analysis. A 2x2 ANOVA was used to compare the effects of defeat and drug on FOS-IR in the 
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CeA, whereas Kruskal Wallis and Mann-Whitney U tests was used to compare the effects of 
defeat and drug on FOS-IR in the BLA, as the BLA data were non-normal. 
Figure 2 shows the injections sites for all animals. Figure 3 is a representative 
photomicrograph of FOS-IR in the BLA indicating where FOS-IR was analyzed following mPFC 
administration of BDNF or saline in defeated and non-defeated animals. 
 
4.4.1 Basolateral amygdala  
As shown in Figure 4, there is a statistically significant main effect of defeat on FOS-IR in 
the BLA (U=74.00, p<0.05).  Defeated animals (n=30;Mdn=7) had increased FOS-IR as 
compared to no defeat animals (n=15;Mdn=1). Furthermore, there is a statistically significant 
main effect of drug on FOS-IR in the BLA (U=143.50, p<0.05). Animals receiving a 
microinjection of BDNF (n=22;Mdn=7) had increased FOS-IR as compared to animals receiving 
a microinjection of saline (n=23;Mdn=0). Further analysis revealed that defeated animals that 
received BDNF (n=15) have a significant increase in FOS-IR in the BLA as compared to defeated 
animals receiving saline (n=15) (U=62.50,p<0.05). Similarly, no-defeat animals treated with 
BDNF (n=8) also demonstrated a significant increase in FOS-IR in the BLA as compared to no-
defeat animals receiving saline (n=8) (U=6.00,p<0.05). 
4.4.2 Central Amygdala  
As shown in Figure 5, there is a statistically significant group difference in FOS-IR in the 
CeA between defeat (n=30) and no-defeat animals (n=15) (F (1,41)=0.182, p<0.05). There were 
no main effects for drug administered via microinjection (BDNF or saline) (F (1,41)=15.022, 
p>0.05). Furthermore, no interactions were found between drug and defeat (F (1,41)=0.570, 
p>0.05). 
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4.5 Discussion 
Our current results demonstrate that BDNF administered directly into the mPFC after 
social defeat stimulates neural activity in the BLA, as measured via FOS-IR. These data 
demonstrate that BDNF in the mPFC can alter BLA activation, but it is not clear that this would 
alter behavioral output given that the BLA activation is not associated with a concurrent 
activation of its major output pathway, the CeA.  We originally expected that BDNF 
administered into the PL would enhance defeat-induced FOS-IR in the BLA and CeA, whereas 
BDNF administered into the IL would suppress defeat-induced FOS-IR in the BLA and CeA. 
This result clearly was not found, and there are a number of factors that could explain this. It is 
important to note, however that we did observe the expected increases FOS-IR in the BLA and 
the CeA of defeated as compared to no-defeat animals, which replicates previous findings of our 
laboratory and others (Bourne et al., 2013; Nikulina et al., 2008; Markham et al., 2010; Kollack-
Walker et al., 1997; Kollack-Walker et al., 1999) and serves as a positive control to demonstrate 
that our immunohistochemical procedures were adequate.   
As stated above, BDNF administered into the mPFC following defeat increases FOS-IR in 
the BLA. Thus, it is possible that BDNF-active drugs alter behavioral responses to social defeat s 
via the connections between the mPFC and BLA. An important caveat to this possibility, 
however, is that we also found that BDNF administered into the mPFC does not alter FOS-IR in 
the CeA, the output center of the BLA. This suggests that the administration of BDNF in the 
mPFC activated neurons in the BLA that do not in turn excite or promote neural activity in the 
CeA. The BLA is composed of 2 major types of neurons: inhibitory GABAergic (gamma-amino 
butyric acid) interneurons and excitatory glutamatergic pyramidal neurons (reviewed in Pape 
and Pare, 2010), both of which express FOS-IR when activated (Hale et al., 2010; Lukkes et al., 
2012). In fact, GABAergic interneurons outnumber glutamatergic projection neurons as 
identified using electrophysiological recording techniques (Rainnie, Asprodini, & Shinnick-
Gallagher, 1993; Likhtik et al., 2006). In order to determine the cell types activated in the BLA 
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following the administration of BDNF in the mPFC, double-labeled immunohistochemistry 
studies are needed. Our current results only examine FOS-IR independently. We are therefore 
unable to comment on what types of neurons are activated in the BLA following the 
administration of BDNF in the mPFC, but the lack of concurrent stimulation in the CeA and the 
previous finding that BDNF and TrkB agonists reduce CD suggests that the FOS activation is 
occurring in cells other than glutamatergic projection neurons.  
Our current findings may suggest that BDNF administered site specifically into the 
mPFC enhances neural activity in GABAergic interneurons in the BLA, as other laboratories 
have found that FOS-IR can be measured in GABAergic interneurons in the BLA (Hale et al., 
2010; Lukkes et al., 2012).  If this is the case in the current study, enhanced activity in 
interneurons would suggest an increase in the inhibitory tone in the BLA, which should result in 
a decrease in submissive and defensive behavior in Syrian hamsters after social defeat. As FOS-
IR in the CeA did not change, we speculate that the BLA is not sending excitatory impulses to 
the CeA. An increase in GABAergic activity in the interneurons, as measured by FOS-IR in the 
BLA, would be consistent with recent findings from our lab that CD is reduced following 
peripheral administration of a TrkB agonist (Jeffress et al., in preparation). Thus, one possibility 
is that BDNF in the mPFC may reduce submissive behavior in Syrian hamsters via enhanced 
GABAergic signaling in the BLA. However, without double-label immunohistochemistry studies 
and behavioral studies with BDNF microinjections in the mPFC, this is only speculation. 
An alternative explanation for the current findings is that BDNF in the mPFC did 
stimulate FOS in glutamatergic project neurons, which is what is most commonly expected, but 
that this drug treatment also stimulated other neurons that were able to dampen the 
downstream response in the CeA.  This could occur if neurons in the intercalated cells between 
the BLA and CeA were also stimulated by mPFC BDNF injections.  This is a reasonable 
possibility given that the mPFC projects to these cells (Vertes, 2004; Gabbott, 2005; also 
reviewed in Pape & Pare, 2010), and they are known to inhibit fear-like responses and to 
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promote extinction of fear memories (reviewed in Pape & Pare, 2010).  Future studies should 
examine the possible role of these cells in this pathway.  
Originally, we expected that BDNF administered into the PL would enhance defeat-
induced FOS-IR in the BLA and CeA, whereas BDNF administered into the IL would suppress 
defeat-induced FOS-IR in the BLA and CeA. It is possible that the volume of BDNF used for our 
current microinjections in the PL and IL was too large and thus BDNF may have diffused 
between the 2 adjacent nuclei.  However this is unlikely, given that the injection volume used 
was minimized in attempts to reduce this concern. It is more likely that reciprocal projections 
between the PL and IL are altered by defeat and BDNF injections (Hoover & Vertes, 2007), and 
thus activity between the 2 cortical nuclei is altered independently prior to altering downstream 
activity in the BLA. To date, the projections between the 2 cortical nuclei have not been 
neurochemically identified (Sangha et al., 2012), thus without additional studies it is unclear 
how BDNF may mediate or alter these projections to mediate a net response from the mPFC 
leading to increased activity in the BLA. 
In conclusion we have found that BDNF administered into the mPFC alters FOS-IR in 
the BLA, a down stream target of the mPFC, following social defeat. These results suggest that 
BDNF in the mPFC may act to reduce CD in Syrian hamsters by altering activity of the BLA. 
Additional work, however, is necessary to clarify how changes in neuronal activity in specific cell 
types within this circuit mediate behavioral changes.  Our findings, in turn, suggest that this 
circuit is one of the ways in which BDNF may mediate behavioral changes following social defeat 
in hamsters and this possibility should be tested directly in future studies. 
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4.7 Figures  
 
 
 
Figure 4.1. Expected neuronal activation following rhBDNF microinjections.  The pattern shown in the 
upper panel would be expected to be associated with enhanced CD and the pattern in the lower panel would be 
expected to be associated with reduced CD (adapted from Vidal-Gonzalez et al., 2006; Sierra-Mercado et al., 2011).  
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Table 4.1.  Average number of FOS-IR positive cells in the BLA following administration of saline or rhBDNF into 
the PL or IL. PL and IL were collapsed into the mPFC for statistical analyses.  
 
PL-Saline IL-Saline PL-
rhBDNF 
IL-
rhBDNF 
   
   
     
BLA FOS-IR IN 
DEFEATED 
ANIMALS 
(AVG + SEM) 
 
7.30+1.06 6.65+0.95 9.31+1.25 9.04+0.44  
  
BLA FOS-IR IN NO-
DEFEAT ANIMALS 
(AVG + SEM) 
3.51+0.26 3.94+0.40 5.08+0.38 6.03+0.88    
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Figure 4.2. Histological re-creation of injection sites of animals receiving unilateral infusions of rhBDNF or saline in the 
mPFC (approximately 3.2mm-2.4mm anterior to bregma). (Dots) Each symbol represents the site of injection in one or more animal 
(pink: no-defeat saline; purple: defeat saline; green: no defeat BDNF; blue: defeat BDNF). Red triangles represent misplaced 
injection sites. Drawings are adapted from Morin and Wood (2001). 
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Figure 4.3.  A representative photomicrograph of FOS-IR in the BLA. Photomicrograph taken at 10X 
magnification approximately 1.2 mm posterior to bregma. The BLA is outlined in the photomicrograph) and  the 
drawing adapted from Morin and Wood (2001) indicates where FOS-IR was counted in the BLA. Black dots indicate 
FOS immunopositive nuclei.  
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Figure 4.4 FOS-IR in the BLA following microinjections of BDNF into the mPFC after a defeat experience. 
Animals experiencing social defeat had significantly more FOS-IR in the BLA as compared to no-defeat animals. 
BDNF administered via microinjection into the mPFC (PL or IL) further increases defeat-induced FOS-IR in the BLA. 
Individual letters represent a significant difference (p<0.05) between groups. 
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Figure 4.5. Main effect of defeat in the CeA. Defeated animals had significantly more FOS-IR in the CeA as 
compared to no-defeat animals. BDNF administered into the mPFC, however, does not alter defeat-induced FOS-IR 
in the CeA. There are also no interactions between defeat x BDNF administration. * Indicates a significant main effect 
(p<0.05) of defeat on FOS, which was significantly higher in defeated animals.. 
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5 CONCLUSIONS  
5.1 Summary of Basic Findings, Caveats and Some Future Directions 
Humans, like most social species, continually interact with conspecifics, and social 
stress-related symptoms are often a common outcome of these interactions. Given that we as a 
society are faced with pervasive social stress and that this exposure can exacerbate psychiatric 
disorders, it is not surprising that stress is a pertinent topic within our society and within the 
field of neuroscience. One of the most common ways for our field to study the neurobiology of 
this unavoidable and important relationship is by using animal models. Animal models provide 
an ethically acceptable and ethologically relevant way to explore the neurobiological 
concomitants of social stress. Conditioned defeat (CD) is one model that allows us to examine 
the natural effects of social stress in the form of social defeat in Syrian hamsters, and this model, 
unlike other resident-intruder models, does not require special arrangements (e.g., complex 
housing conditions) to stimulate aggression but instead takes advantage of the natural territorial 
and aggressive tendencies of Syrian hamsters. Brief agonistic encounters in hamsters are also 
not associated with tissue damage from bites, unlike that found in widely used mouse models of 
defeat, so the response to defeat in this species most likely is not confounded by an 
inflammatory response. Additional advantages of this model include 1) our established 
knowledge of the putative circuit underlying CD and 2) our understanding of some of the 
cellular and molecular mediators that may also be involved in this social stress-induced 
behavioral change.  
One neurotropic factor that has garnered attention as an important modulator of stress 
responding, learning, and neuronal plasticity is brain derived neurotrophic factor (BDNF). 
Unfortunately, it is still unclear how BDNF is involved in stress responses because some studies 
suggest that it is important for fear learning and that it amplifies stress responding, whereas 
other studies indicate that BDNF reduces the effects of stress, promotes resilience, and underlies 
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the effectiveness of antidepressants. The overarching goal of the current project was to more 
clearly define the role of BDNF in CD and to begin to define where in the neural circuit 
mediating CD BDNF has its effects. Given previous work from our lab and others using k252a, a 
nonspecific Trk receptor antagonist, we originally hypothesized that BDNF, via activation of 
tyrosine kinase B (TrkB) receptors, is necessary for fear learning (Rattiner et al., 2004; Taylor et 
al., 2011; reviewed in Mahan & Ressler, 2012). We demonstrated that activating TrkB receptors 
via microinjections of rhBDNF into the basolateral amygdala (BLA), however, supports the 
alternative hypothesis that BDNF protects against the effects of social defeat stress as measured 
by a reduction in subsequent submissive behaviors in previously defeated hamsters. Thus, 
BDNF in the BLA appears to be sufficient to produce a reduction in CD, a response that can be 
interpreted as increased resilience to the social defeat stressor.  
As this finding was counter to what we expected, we hypothesized that it was possible 
that BDNF could promote CD by acting in other nuclei within the CD circuit and that potentially 
opposing actions of BDNF could result in a different net effect if the pharmacological agents 
were given systemically. Thus, we initially set out to characterize the effect of global 
manipulation of TrkB receptors with systemic injections. This approach seemed a good first step 
because of our concerns about the vehicle in which these drugs were dissolved, and it had the 
added benefit of having potential translational implications because pharmacological 
manipulations in humans would almost certainly be systemic. We demonstrated that the 
specific TrkB receptor agonist, 7,8- dihydroxyflavone (7,8-DHF), administered peripherally 
reduces submissive behavior when administered immediately prior to or immediately after 
social defeat. This is consistent with the hypothesis that BDNF reduces CD via binding at Trk B 
receptors. In addition, systemic administration of a TrkB receptor antagonist, ANA-12 ([N2-2-2-
Oxoazepan-3-yl amino] carbonyl phenyl benzo (b) thiophene-2-carboxamide), immediately 
after social defeat increases submissive behavior. Together, the current findings strongly 
suggest that BDNF does not promote CD learning but, instead, that it reduces behavioral 
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responses to social stress in Syrian hamsters.  Finally, this study suggests that these effects are 
mediated at least in part in the BLA.  
Earlier studies indirectly suggested that BDNF was necessary for CD when a nonspecific 
Trk antagonist, k252a was used, but they also measured BDNF mRNA, to assess the potential 
response of BDNF systems to social defeat. The findings suggested that BDNF was stimulated by 
defeat in the BLA because the mRNA was highest in defeated hamsters. In order to better clarify 
how social stress alters BDNF, we examined BDNF protein because changes in mRNA are not 
always associated with changes in the corresponding protein, and it is the protein that underlies 
the biological processes. It is possible, given our current findings, that the increase in BDNF was 
not associated with a concomitant increase in the protein product or that it increased pro-
BDNF, which is known to have an opposite effect to BDNF (Lu, Pang, & Woo, 2005). We did 
examine BDNF protein in serum and brain following social defeat, but did not find any 
significant changes in the protein (see Appendix A).  Although these data are not definitive, they 
do suggest that the changes in BDNF mRNA following defeat are not necessarily reflected in 
concomitant changes in BDNF, at least when examined in serum or in dissected brain regions of 
interest.   
It also appears that k252a reduced the acquisition of CD in our earlier study via an 
alternative mechanism besides BDNF/ TrkB signaling. It is important to note that k252a, which 
has often been promoted in the literature as a BDNF receptor antagonist, actually blocks 
numerous kinases in the Trk receptor family (Arthur et al., 2005, Berg et al., 1992, Koizumi et 
al., 1988, Sofroniew et al., 2001) including TrkA receptors, the receptors for nerve growth factor 
(NGF). Thus, one possible alternative is that a blockade of NGF signaling caused the reduction 
in CD following k252a administration (Taylor et al., 2011) and that it is, instead, NGF that 
promotes CD learning. We have completed a study to examine this possibility, however, and we 
found that administration of gambogic amide, a specific TrkA agonist, immediately after social 
defeat does not alter submissive behavior (see Appendix B). Although TrkA receptors do not 
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appear to play a role in CD, it is likely that the behavioral effects of k252a are mediated via 
another kinase(s) in signaling pathways of BDNF (e.g., mitogen activated protein kinase) or via 
another protein kinase altogether.  Future studies should address this question. 
Next, it was of primary interest to determine other sites in our putative CD circuit that a 
systemic TrkB agonist might be acting to induce the observed behavioral changes (i.e., the 
increase in submission and the decrease in territorial aggression). The activation of the 
immediate early gene c-fos was used as a marker to begin to determine in which of these nuclei 
the systemically administered drugs might act. Because BDNF microinjected into the BLA 
reduces submission in defeated hamsters, we anticipated that neural activity would change at 
least in the BLA and perhaps in other nuclei, as well, following the peripheral administration of 
a TrkB receptor agonist. Unfortunately, we could not address our original hypothesis because 
the vehicle in which 7,8-DHF must be dissolved contained 40% dimethyl-sulfoxide (DMSO), 
which appeared to stimulate FOS activation in a subset of sites within the CD circuit and 
therefore confounded our FOS-immunoreactivity (FOS-IR) data. In addition, it appeared that 
7,8-DHF reduces this DMSO-induced FOS-IR in the BLA and the central amygdala (CeA), 
regardless of the behavioral manipulation (i.e., defeat or no defeat). Fortunately, we had 
included a saline-treated group as a positive control and were able to replicate that defeated 
hamsters displayed significant increases in FOS-IR in the BLA as compared to no-defeat 
animals suggesting that the anomalous findings were due to confounds introduced by the drug 
or vehicle and not by overall problems with our immunohistochemical procedures.  
Finally, the third aim examined whether BDNF administered in the mPFC (i.e., PL or IL) 
following a behavioral manipulation (i.e., defeat or no-defeat) would alter FOS-IR in the BLA.  
Overall, the results demonstrated that this BDNF may act to modulate responses to social stress 
via this pathway. BDNF in the mPFC was effective in altering defeat-induced FOS-IR in the BLA, 
although the stimulation of FOS in the BLA may not be the first prediction made based on the 
finding that BDNF in the BLA suppresses CD. Drug administration in the mPFC did not alter 
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FOS-IR in the CeA, however, which suggests that the BLA activation is not associated with a 
stimulatory output to the CeA.  The most parsimonious explanation for these findings are that 
the FOS activation found in the BLA is in inhibitory interneurons rather than excitatory 
projection neurons. Again, we were able to demonstrate that defeat significantly increases FOS-
IR in the BLA and the CeA as compared to no-defeat animals, which replicates previous findings 
of our laboratory and suggests that our immunohistochemical procedures were again sound.  A 
disappointing finding in this study was that we were unable to demonstrate that the IL and PL 
within the mPFC have opposing effects on the BLA as has been demonstrated previously in the 
literature using traditional fear conditioning procedures.  It may be that there is an important 
species difference in the structure and role of this brain area in hamsters or that these brain 
areas do not having opposing effects on brain and behavior following social defeat stress.  It is 
also reasonable to speculate that our methodology was unable to tease apart the separate roles 
of these contiguous nuclei because of their very close proximity.  Future studies should 
reexamine this question to elucidate the roles of the IL and PL in brain and behavioral responses 
to social defeat in hamsters.   
5.2 Contributions of the Findings to the Field and Clinical Implications 
Despite our results that specific TrkB agonists reduce submission being opposite to what 
we had initially predicted, they are consistent with an alternative hypothesis that BDNF 
promotes resiliency to stress (reviewed by Russo et al., 2012; Karatsoreos & McEwen, 2011). 
Interestingly, BDNF is suppressed following exposure to stress in humans, and reduced BDNF 
protein in serum is observed in patients with numerous psychiatric illnesses, as discussed 
previously in this document (Karege et al., 2002; reviewed by Duman and Monteggia, 2006; 
Castren & Rantamaki, 2010;Dell’osso et al., 2009; review by Rakofsky et al., 2012; Suliman, 
Hemmings, & Seedat, 2013; Dwivedi, 2010). Furthermore, it is thought that diminished BDNF 
signaling following stress might be an underlying factor in the development of psychiatric 
105 
disorders. Restoring BDNF signaling also plays a critical role in the treatment of these disorders, 
as BDNF levels are normalized after antidepressant treatment, and blocking BDNF abolishes the 
effectiveness of antidepressant treatment in rodent models (Karege et al., 2002; reviewed by 
Duman and Monteggia, 2006; Castren & Rantamaki, 2010; Suliman, Hemmings, & Seedat, 
2013; Saarelinen et al., 2003). Furthermore, BDNF in the mPFC and the hippocampus has 
antidepressant actions (reviewed in Duman, 2014), suggesting that when we administer a TrkB 
receptor agonist peripherally it may be acting to promote the activation of these brain regions, 
which, in turn, inhibits the effects of stress (i.e., defeat). Given the potential translational 
applications of BDNF as an antidepressant or as a molecule that reduces the effects of stress 
(e.g., promotes resiliency), it is of particular interest to note that our peripheral injection of a 
TrkB receptor agonist produced a pro-resilient response (e.g., a reduction in the behavioral 
response to social stress). This finding supports the possibility that BDNF-active drugs could be 
an effective treatment for those suffering from several stress-related psychopathologies, 
including PTSD and depression (Altar 1999, Duman 2004, Duman & Monteggia 2006).  
The findings discussed above illustrate that peripheral administration of DMSO as a 
vehicle in rodents is not ideal. Visual observations of hamsters following IP administration of 
DMSO reveals changes in behavioral responses including unusual behavioral posturing such as 
stretching and hopping (personal observations). Weiczner et al. (2008) also report changes in 
animal behavior following IP administration of DMSO in rats. DMSO, itself, is also reported to 
have numerous effects on neurons (Stewart, Herrrera, & Nordheim, 1990; Lu & Mattson, 2001; 
Tsvyetynska et al., 2005). The current work reinforces the wide range of effects of DMSO that 
are often ignored but that should be considered in the future as potential confounds.  
Overall, the current project only begins to address our overarching question about the role 
of BDNF in CD. Additional work is clearly needed to address the remaining questions that we 
have introduced throughout this document. At this time, however, our data do appear to 
indicate that BDNF acting via TrkB receptors reduces the effects of stress typically observed in 
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Syrian hamsters after social defeat stress. This change in behavioral responses to stress appears 
to be mediated at least in part via the BLA and its connections with the mPFC.  
5.3 Remaining Questions and Additional Future Directions 
 The findings in the current project have begun to clarify the complex role of 
BDNF in CD, but additional research is needed to better characterize the role of this molecule in 
conditioned defeat. First and foremost, studies should examine how BDNF is modulating 
numerous other neurotransmitter systems including GABAergic and glutamatergic neurons at 
both a behavioral and a cellular level. GABAergic interneurons and glutamatergic pyramidal 
neurons are 2 types of neurons found in the BLA (reviewed in Pape and Pare, 2010), both of 
which express FOS-IR when activated (Hale et al., 2010; Lukkes et al., 2012).  In order to 
determine the cell types activated in the BLA following the administration of BDNF in the 
mPFC, double-labeled immunohistochemistry studies are needed. Our current study only 
examined FOS-IR; we are therefore unable to comment on the phenotype of the neurons that 
are activated in the BLA following the administration of BDNF in the mPFC. Given that a recent 
review examined how reducing BDNF signaling alters neuronal transmission at both 
glutamatergic and GABAergic synapses (Ninan, 2014) suggests that BDNF has quite complex  
effects on synaptic plasticity and neuronal transmission within the putative CD circuit that may 
mediate behavioral responses in highly nuanced ways depending on the animal’s particular 
experience.   
Without additional double label immunohistochemistry studies, we must speculate on 
what our current findings suggest regarding the role of BDNF in the mPFC in our CD model. The 
most parsimonious explanations for our current findings, however, is that BDNF administered 
site specifically into the mPFC enhances neural activity in GABAergic interneurons in the BLA.  
This is consistent with the finding that FOS-IR can be measured in GABAergic interneurons in 
the BLA (Hale et al., 2010; Lukkes et al., 2012).  If this is the case in the current study, enhanced 
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activity in GABAergic interneurons would increase the inhibitory tone in the BLA that would in 
turn lead to a decrease in submissive and defensive behavior in Syrian hamsters after social 
defeat. FOS-IR in the CeA did not change following the current manipulation, which is 
consistent with the hypothesis that the BLA is not sending excitatory impulses to the CeA.  It is 
also possible that BDNF in the mPFC suppresses cellular activation in the CeA either via a direct 
projection to the CeA (Vertes, 2004) or via an indirect projection to the intercalated cell groups 
between the BLA and the CeA (Berretta et al., 2005; Royer, Martina, & Pare, 1999), either of 
which would result in less activation of the CeA.  
An alternative explanation for the above immunohistochemical data is that the FOS-IR is 
primarily reflecting activation within glutamatergic cells, the more typical role that FOS is 
supposed to play. Numerous studies examining FOS-IR in the BLA following stress report that 
glutamatergic projection neurons are activated, which is then reflected in increased excitatory 
output of the BLA (Vyas et al., 2002; reviewed in Roozendaal et al., 2009). Increased FOS-IR in 
glutamatergic neurons in the BLA following administration of BDNF into the mPFC would 
presumably cause an increase in submissive behavior in Syrian hamsters, however. Clearly, 
additional studies are needed to tease apart these possibilities.  One of the first steps should be 
to determine if submission is decreased when BDNF is administered in the mPFC and to 
determine which cells in the BLA are activated by the microinjections of BDNF in the mPFC 
following social defeat.  
Additional studies could consider the role that proBDNF, the pre-cleaved form of BDNF, 
may play in CD when binding to p75 receptors, as this could explain the increased BDNF mRNA 
observed in defeated hamsters (Taylor et al., 2010). The novel TrkB compounds used in the 
current studies specifically target TrkB receptors and therefore purportedly do not interact with 
p75 receptors (Jang et al., 2010; Carloza et al., 2011). However, as pro-BDNF, binds to p75 
receptors and often has the opposite effect of BDNF/TrkB signaling, such as inducing LTD and 
apoptosis (Lu, Pang, & Woo, 2005; Martinowich et al., 2012), it could be interesting to examine 
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how p75 receptors specifically in the amygdala or hippocampus may alter behavioral responses 
to social defeat in Syrian hamsters. To date limited work has been completed to examine this 
possibility. 
Additionally, future studies should begin to investigate the role of BDNF in other nuclei 
within our putative circuit of CD. Examining BDNF within individual nuclei may help to 
elucidate where in the brain BDNF acts to promote or inhibit behavioral responses to social 
stress. Studies should be completed to examine the actions of BDNF in the mPFC on behavior as 
suggested above, given that the mPFC is known to have connections with downstream nuclei 
including the amygdala (Berglind et al., 2007; Choi et al., 2010; Gourley et al., 2009; Choi et al., 
2012) and that our current findings using FOS-IR also demonstrate connectivity that could be 
important for behavioral changes. Furthermore, the work of other labs suggests that BDNF in 
the mPFC may be one molecular mechanism that alters emotional responses and fear learning. 
Another nucleus to focus on is the nucleus accumbens (NAc) and the hippocampus, as a recent 
review suggests that BDNF has pro-depressive actions in the NAc, but antidepressant actions in 
the hippocampus (see Duman, 2014 for review). Specifically, BDNF protein is increased in the 
NAc after 10 days of social defeat (Berton et al., 2006), and altered levels of BDNF in the NAc, 
may, therefore, explain how some animals are susceptible to the negative effects of social stress 
whereas other animals are resilient (Krishnan et al., 2007). The NAC is thus an intriguing 
nucleus that should be examined given our own findings about the role of BDNF in CD. 
Alternatively, stress and the administration of corticosterone into the hippocampus decreases 
BDNF mRNA and protein (Kozlovsky et al., 2007; Jacobsen et al., 2006). Nevertheless, repeated 
social stress reduces BDNF mRNA in the hippocampus (Nibuya et al., 1999), and given the role 
of the hippocampus in learning and memory, it is also an interesting nucleus in which to 
examine the effects of BDNF on CD. It is critical to remember that all of the nuclei examined in 
this project and the additional nuclei we propose for future examination are part of an 
interactive neural network. Recent work in rats, for example, found that BDNF protein levels 
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increase in the hippocampus, simultaneously decrease in the ventral tegmental area (VTA), and 
interestingly, not all of these changes are critical for antidepressant-like effects of 
electroconvulsive therapy (ECT) (Taliaz et al., 2013). Thus, the potential changes within the 
nuclei we examine are only a “snapshot” of activity within a single nucleus that is part of our 
dynamic circuit, and furthermore may not even be critical for observed behavioral changes. 
Recent work also suggests that the environment plays a large part in the regulation of BDNF, 
therefore suggesting that the environment even beyond the stressor should also be considered in 
future studies examining BDNF in the proposed nuclei of interest (reviewed in Karpova, 2014). 
It is critical that all future experiments consider limitations we have discovered 
surrounding BDNF. First, investigators should be aware of the vehicle in which novel 
compounds for specific receptors are dissolved in for administration. BDNF, itself, cannot cross 
the blood brain barrier (BBB) (Pardridge, 2007), so it is extremely advantageous that novel 
compounds have been developed that can be administered peripherally and that specifically 
target one type of Trk receptor. The only constraint is that most of these compounds must be 
dissolved in solvents such as DMSO. Our initial concerns about this solvent are highlighted in 
FOS-IR studies wherein we found that DMSO increases FOS-IR independently of any other 
manipulation. It is therefore important as scientists strive to develop novel compounds to treat 
neurological disorders, that drug developers continue to be cognizant of effects that some drug 
vehicles, alone, may have on behavior and on cells. 
 A second limitation that should be considered is the timing of manipulations. We may 
not have seen altered FOS-IR, for example, given the timing of our manipulations, as animals 
were initially defeated and then administered a TrkB receptor agonist immediately after defeat 
before being sacrificed 1 h later. As a result there may not have been enough time for BDNF to 
completely reduce or increase neural activity (i.e., FOS-IR) that was already turned on by defeat. 
Timing should also be considered if additional studies are conducted to examine protein 
expression, given that differences may not be observed between defeat and no-defeat conditions 
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in the current work because we missed a critical time point and translation was not complete 
when we harvested the tissue. 
Changes in endogenous BDNF are observed following a stressor in numerous animal 
models. In order to better clarify how social stress alters BDNF, we examined BDNF protein in 
hamsters following an acute social defeat. Measuring protein is preferable to measuring mRNA 
expression as changes in mRNA are not always associated with changes in the corresponding 
protein, and it is the protein that underlies the biological processes. Furthermore, the post-
translational modification of BDNF is not well understood (Nawa et al., 1995). Interestingly, we 
found that there are no differences in BDNF protein expression in the serum, the BLA, the PL, 
or the IL following defeat in hamsters (Appendix B). These findings suggest that defeat does not 
alter BDNF protein levels in Syrian hamsters as compared to no-defeat animals, at least when 
examined 2.5 h after defeat, which is during the consolidation period. Given that we have shown 
that BDNF administered into the BLA immediately after defeat reduces the consolidation of CD, 
and others in our lab found that BDNF mRNA is increased in the BLA 2 h after defeat, we were 
surprised that there were no differences in protein expression. Differences in BDNF protein 
have been reported at this time point previously (Duclot & Kabbaj 2013).  Thus, additional time 
points may helpful to determine if BDNF is altered by defeat in Syrian hamsters.   These 2 
limitations of current studies should be considered in the design of future studies examining the 
role of neurotrophins in CD. 
Brain derived neurotrophic factor is an extremely important protein in our nervous 
system as it regulates synaptic growth, plasticity, and neuron development (Adachi et al., 2014; 
Chao et al., 2006). In addition, research in the last several years has indicated that this molecule 
is involved in fear learning and stress, which, in turn, has clinical implications in disorders such 
as depression and PTSD. As BDNF has such wide-ranging effects, it is imperative that we 
continue to determine ways in which to isolate this protein’s role in behavioral responses and in 
neuronal activity following social defeat in Syrian hamsters. Our data suggest that BDNF is a 
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molecule that prevents social stress-induced changes in Syrian hamsters at least in part via the 
BLA and perhaps the MPFC.  Furthermore, this work suggests that BDNF/TrkB active 
compounds may be a potential treatment for stress-related neuropsychiatric disorders in 
humans.   
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APPENDICES  
Appendix A: Defeat does not change BDNF protein expression in serum, the BLA, 
the PL or the IL 
Appendix A.1: Introduction 
Previous work from our lab indicates that BDNF mRNA was increased in the BLA of 
defeated hamsters (Taylor et al., 2011). Whereas, others have reported findings in mice that 
BDNF mRNA is reduced 24 h after social defeat stress in the hippocampus, BLA, and parts of 
the cortex (Pizzaro et al., 2004) however, many labs have examined BDNF protein levels in 
these same nuclei. Measuring protein is preferable to measuring mRNA expression as, the post-
translational modification of BDNF is not well understood (Nawa et al., 1995), and changes in 
mRNA are not always associated with changes in the corresponding protein.  Several labs have 
examined BDNF protein levels in several different brain nuclei involved in stress and fear 
learning, and interestingly, the changes in BDNF appear to be nucleus-dependent (reviewed in 
Sakata, 2013) and, as reported previously, are inconsistent. BDNF protein expression, for 
example, is increased in the mPFC by repeated social stress in mice (Nikulina et al., 2012) and in 
the amygdala following chronic stress (reviewed by Boyle, 2013) while others, however, report 
that social stress reduces BDNF protein in the amygdala, the hypothalamus, and the 
hippocampus (Fanous et al., 2010; Pizarro et al., 2004).  
In attempts to clarify how defeat alters BDNF, and in turn reduces CD, we examined 
BDNF protein in hamsters, specifically in the in serum, the BLA, the PL, and the IL of defeated 
and no defeated hamsters.  
 
Appendix A.2: Materials & Methods 
Animals and Housing Conditions 
Subjects were male Syrian hamsters (Mesocricetus auratus, Charles River Laboratories, 
New York, NY) that weighed 120-140 g and were between 9-10 weeks old at the time of testing. 
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All hamsters were handled for five days prior to behavioral procedures to acclimate them to 
experimenter handling, and singly housed in polycarbonate cages (20x 40 x 20cm) with corncob 
bedding and wire mesh tops in a temperature (20 ± 2° C) and humidity-controlled room. The 
room was maintained on a 14:10 light dark cycle with lights off at 10:00 am. Food and water 
were available ad libitum. Older hamsters (>6 months), which were individually housed (>1 
month) and weighed at least 180g served as resident aggressors (RA) in defeat training for all 
experiments. All procedures and protocols were approved by the Georgia State University 
Institutional Animal Care and Use Committee and are in accordance with the standards outlined 
in the National Institutes of Health Guide for Care and Use of Laboratory Animals. 
 
Social Defeat  
 The CD model has been described elsewhere (Huhman et al., 2003). Prior to 
training, hamsters were matched by weight and then randomly assigned to groups. All animals 
were transported in their home cage to the behavioral testing suite within the animal vivarium 
30 min prior to all behavioral manipulations in order to acclimate. All behavioral procedures 
were performed in the first 3 h of the dark phase of the daily light: dark cycle to minimize any 
circadian effects. Social defeat training occurred in the home cage of the RA for 15 min. In all 
experiments, no-defeat controls were placed into an empty RA cage.  
 
Sample Collection and Preparation 
Hamsters were rapidly decapitated 2.5 h after a 15 min social defeat. Brains were 
removed on dry ice, and then stored at -80°C until dissection and homogenization. Frozen 
brains are slowly brought to -20°C and sectioned in a cryostat. From these sections, 1-2mm 
punches were taken of the BLA and mPFC. Trunk blood was collected in centrifuge tubes, and 
spun at 4°C at 3000rpm for 30 mins. Serum was then pulled off and then stored at -20°C until 
use. 
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Assay Validation 
All assay kits were validated using tissue and serum samples. We determined linearity of 
sample dilution by serially diluting tissue and serum samples to 1:2, 1:4, 1:8, and 1:16 in sample 
buffer. The intra-assay precision was determined as the mean coefficient of variation (CV), and 
test reproducibility was determined as the mean CV of analyses from 5 different assays. 
 
Enzyme- linked immunosorbent assay for Serum BDNF 
Tissue and serum samples were processed using BDNF Emax Immunoassay kit 
(Promega; Madison, WI) as described previously (Haenisch et al., 2008; Rost et al., 2005) with 
modifications for use with Syrian hamsters (Ma et al., 1998). Serum samples were diluted in 1:8 
buffer and Tissue samples were diluted in 1:2 buffer (Ma et al., 1998). According to the 
manufacturer, this kit detects a minimum of 15.6 pg/ml of BDNF and demonstrates less than 3% 
cross-reactivity with the other neurotrophins (e.g., NGF).  
 
Total Protein Quantification 
BDNF concentration in each serum and tissue sample was calculated not only by the 
amount of protein per milliliter sample, but also by the amount per milligram of total sample 
protein. Total protein in each sample was measured using Lowry Protein Assay (Bio-Rad; 
Hercules, CA). Serum samples were diluted to 1:128 and tissue samples were also diluted 1:32 
for protein analysis. 
 
Statistical Analysis 
The total volume of BDNF (pg/ug) in each sample was calculated (i.e., accounting for 
dilution factors and dividing BDNF expression by total protein expression) and compared 
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between defeat and no-defeat conditions.  All data were analyzed using independent t-tests. 
Criterion for significance was p<0.05. 
 
Appendix A.3: Results 
We found no differences in BDNF expression in serum (t (22)=1.840,p>0.05) (Figure 1), 
the BLA (t (22)=0.002,p>0.05)  (Figure 2), the PL (t (22)=0.375,p>0.05) (Figure 3), or the IL (t 
(22)=4.949,p>0.05)  (Figure 4), which suggested that defeat does not alter BDNF protein levels 
in Syrian hamsters 2.5 h after defeat. 
 
Appendix A.4: Discussion 
We found no differences in BDNF protein in the periphery (as measured in serum) or in 
3 brain nuclei of interest: the BLA, the PL and the IL. Given we have shown that BDNF 
administered into the BLA reduces the consolidation of CD (Jeffress et al., in preparation) and 
that defeat increases BDNF mRNA in a nucleus dependent fashion (Taylor et al., 2011), we were 
surprised that there were no differences in BDNF protein expression. These findings may 
suggest that BDNF binds to TrkB receptors and in turn activates another transmitter system 
(e.g., GABA) or second messenger cascade (i.e.PI3K and ERK) that is ultimately responsible for 
the observed behavioral changes without up changing BDNF protein, 2.5 h after defeat. Future 
studies should examine BDNF protein expression at additional time points after defeat. 
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Appendix A.6: Figures 
 
 
Figure A.6.1 BDNF protein expression was examined in the serum of Syrian hamsters following a brief 
defeat or no defeat experience.  No differences were found in BDNF expression (pg/ug) in the serum of defeated 
hamsters as compared to  no defeat hamsters 2.5 h after a brief social defeat using an Emax Immunoassay kit.  
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Figure A.6.2  BDNF protein expression was examined in the basolateral amygdala of Syrian hamsters 
following a brief defeat or no defeat experience. No differences were found in BDNF expression (pg/ug) in the 
basolateral amygdala of defeated hamsters as compared to no defeat hamsters 2.5 h after a brief social defeat using an 
Emax Immunoassay kit. 
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Figure A.6.3 BDNF protein expression was examined in the prelimbic cortex of Syrian hamsters 
following a brief defeat or no defeat experience. No differences were found in BDNF expression (pg/ug) in the 
prelimbic cortex of defeated hamsters as compared to no defeat hamsters 2.5 h after a brief social defeat using an 
Emax Immunoassay kit. 
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Figure A.6.4 BDNF protein expression was examined in the infralimbic cortex of Syrian hamsters 
following a brief defeat or no defeat experience. No differences were found in BDNF expression (pg/ug) in the 
prelimbic cortex of defeated hamsters as compared to no defeat hamsters 2.5 h after a brief social defeat using an 
Emax Immunoassay kit. 
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Appendix B: Gambogic Amide administered peripherally does not alter the 
consolidation of CD 
Appendix B.1: Introduction 
Our lab has previously demonstrated that k252a, a nonspecific tyrosine kinase (Trk) 
receptor antagonist, reduces submissive behavior in defeated hamsters (Taylor et al., 2011). 
k252a, which has often been used as a BDNF receptor antagonist, actually blocks numerous 
protein kinases including members of the Trk receptor family (Arthur et al., 2005, Berg et al., 
1992, Koizumi et al., 1988, Sofroniew et al., 2001) such as TrkA receptors, the receptors for 
nerve growth factor (NGF).  Therefore, use of k252a is not ideal as it leaves unanswered the 
question of which neurotrophin mediates subsequent changes. Thus, one possible alternative is 
that a blockade of NGF signaling caused the reduction in CD following k252a and that it is 
instead NGF that promotes CD learning. To date, there are no TrkA antagonists commercially 
available, however, a TrkA receptor agonist, Gambogic Amide has been developed and can be 
administered peripherally (Jang et al., 2007). This experiment, therefore, aims to test whether 
TrkA receptor activation enhances consolidation of CD. 
,  
Appendix B.2: Materials & Methods 
Animals and Housing Conditions 
Subjects were male Syrian hamsters (Mesocricetus auratus, Charles River Laboratories, 
New York, NY) that weighed 120-140 g and were between 9-10 weeks old at the time of testing. 
All hamsters were handled for five days  prior to behavioral procedures to acclimate them to 
experimenter handling, and singly housed in polycarbonate cages (20x 40 x 20cm) with corncob 
bedding and wire mesh tops in a temperature (20 ± 2° C) and humidity controlled room. The 
room was maintained on a 14:10 light dark cycle with lights off at 10:00 am. Food and water 
were available ad libitum. Older hamsters (>6 months), which were individually housed (>1 
month) and weighed at least 180g served as resident aggressors (RA) in defeat training for all 
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experiments, whereas smaller (110g-120g), younger (~ 7 weeks) hamsters were group housed 
and served as non-aggressive intruders (NAI) during CD testing. All procedures and protocols 
were approved by the Georgia State University Institutional Animal Care and Use Committee 
and are in accordance with the standards outlined in the National Institutes of Health Guide for 
Care and Use of Laboratory Animals. 
 
Social Defeat and Behavioral Testing 
 The CD model has been described elsewhere (Huhman et al., 2003). Prior to 
training, hamsters were matched by weight and then randomly assigned to groups. All animals 
were transported in their home cage to the behavioral testing suite within the animal vivarium 
30 min prior to all behavioral manipulations in order to acclimate. All behavioral procedures 
were performed in the first 3 h of the dark phase of the daily light: dark cycle to minimize any 
circadian effects. Social defeat training occurred in the home cage of the RA for 5 min to reduce 
potential ceiling effect. No-defeat animals were placed into an empty RA cage for 5 min to 
expose animals to odors but no physical interaction. Behavioral testing occurred 24 h after 
training for a 5 min period with an NAI in the home cage of the experimental animal.  
 
Behavioral Analysis 
All social defeat training and behavioral testing was recorded via video camera, 
transferred to an external hard drive, and later scored by a observer blind to experimental 
condition using Observer for Windows (Noldus Information Technology B.V., Wageningen, The 
Netherlands; version 7.0). Total durations for 4 classes of behavior were scored during testing 
including: (1) Social (stretch, approach, sniff, nose touching, and flank marking); (2) Non-social 
(locomotion, exploration, grooming, nesting, feeding and sleeping); (3) Submissive (flight, 
avoidance, tail up, upright and side defense, full submissive posture, stretch attend, attempted 
escape from cage); (4) Aggressive (upright and side offense, chase and attack, including bite). 
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Drug Administration 
Animals (n=69) were randomly assigned to groups (defeat or no defeat) and within these 
2 conditions, animals received either 0.2 mg/kg of Gambogic Amide (Enzo Life Sciences; 
Farmingdale, NY) dissolved in 100% Dimethylsulfoxide (DMSO), used previously (Jang et al., 
2007) or vehicle (100% DMSO) immediately after a 5min defeat. Post-training drug 
administration was used because the TrkA drugs were only soluble in DMSO solutions, and this 
vehicle solution caused the subjects to have an odor that was discernable by the investigators; 
therefore, post-training injections were used so that the subjects would have normal odors 
during defeat training. As described above, animals were tested drug free 24 h later in their 
home cage with an NAI for 5 min. 
 
Statistical Analysis 
The total duration (seconds) of submission, aggression, social and non-social behaviors 
were determined. All data were analyzed using 2X2 ANOVAs. Criterion for significance was 
p<0.05. 
Appendix B.3: Results 
 
Gambogic Amide administered peripherally does not alter the consolidation 
of CD  
As shown in Figure 1, hamsters receiving a 0.2mg/kg IP injection of Gambogic Amide 
after defeat did not alter submissive and defensive behavior (F (1,63)=1.627, p>0.05) when 
tested 24 h later. No significant differences were observed for non-social, social, or aggressive 
behavior. 
Gambogic Amide did not have an effect on behavior independently in no-defeat controls, 
as there was no interaction (F (1,63)=0.807, p>0.05; data not shown). Furthermore, all defeated 
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hamsters showed a significant increase in submissive behavior as compared to the appropriate 
no-defeat hamsters indicating that exposure to social defeat resulted in conditioned defeat as 
evidenced by a significant increase in the duration of submissive/defensive behavior following 
defeat (F (1,63)=38.318, p<0.05; Table 1). 
 
Appendix B.4: Discussion 
Gambogic Amide, a TrkA receptor agonist administered immediately after social defeat 
did not alter submissive behavior in Syrian hamsters (Figure 1). There appears to be a trend 
suggesting that Gambogic Amide reduces submission behavior, which is interesting considering 
that k252a, a non-specific Trk antagonist reduces submissive behavior in Syrian hamsters when 
administered immediately prior to social defeat. As K252 is reported to act on numerous protein 
kinases, and NGF is also understood to mediate neuron survival, growth, and development as 
well as in learning and memory (Chao et al., 2006; Minichiello, 2009; Autry & Monteggia, 2012; 
Gray et al., 2013) we expected that Gambogic Amide would enhance fear learning. The current 
results that Gambogic Amide does not alter submissive behaviors in Syrian hamsters, however, 
indicate that NGF is not involved in CD.  
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Appendix B.6: Figures 
 
Figure B.6.1 Gambogic amide does not significantly alter the consolidation of social defeat. Behaviors 
exhibited by previously defeated hamsters during a 5min test with an NAI are shown as mean duration (+ standard 
error of the mean). Hamsters received an IP injection of Gambogic amide or vehicle immediately after a 5 min social 
defeat with an RA.  
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Table B.6.1  Mean Duration of Behavior represented as percent of vehicle for No-Defeat 
animals in Consolidation studies. 
Behavior	   Vehicle	   Gambogic	  Amide	  
Submission	   2.76	  +	  1.65	   0.21	  +0.15	  
Social	   146.23+10.34	   168.35+12.87	  
Non-­‐Social	   125.38+10.76	   102.64+14.12	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2013-present, Instructor: Introduction to Biological Aspects of Psychology: 100 
students, 15 weeks  
 
  Georgia State University, Summer Programs 
2012-present, Orientation Teaching Assistant: Behavioral Research 
Advancements In Neuroscience (BRAIN) Summer Research Program for 
Undergraduates  
 
Georgia State University, Supervisory Responsibilities 
2012, Simone Carrey, Institute on Neuroscience (ION) Scholar 
2012, Kaitlin Murdoch, Wheeler High School Senior Project  
2013, Emma Goldman, Institute on Neuroscience (ION) Scholar  
2014, Aminah Matthews, Institute on Neuroscience (ION) Scholar  
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|Invited  
Science  
Education 
Workshops &  
Panels|         
2012, GT-Neuro Brain Awareness Volunteer Workshop, Georgia Institute of 
Technology, March 5th: Workshop on education outreach activities for undergraduates 
to perform in the k-12 classroom 
 
2012, Molecular Mechanisms of Learning and Memory in Aplysia, June 2nd: 
Workshop Consultant for the Behavioral Research Advancements In Neuroscience 
(BRAIN) Summer Research Program for Undergraduates.  
 
2012, Graduate Student Panel, Georgia Institute of Technology, October 31st: 
Educating Undergraduates in an Introduction to Neuroscience Course about Graduate 
School. 
 
|Conference  
Coordination|         
2013, 17th Annual Society for Behavioral Neuroendocrinology Conference: 
Conference Organizer and Host, Held at Loews Midtown, Atlanta, June 2013. 
 
|Scientific  
Societies &  
University  
Committees|       
2008-2009, Neuroscience Club, President  
2008-present, Society for Neuroscience 
2011-present, Neuroscience Graduate Student Association, Undergraduate 
Placement Program Coordinator, Co-Chair for Keynote Speaker 2013-2014 
2012-present, Atlanta Chapter of Society for Neuroscience, Council Member 
2012-present, Society for Behavioral Neuroendocrinology 
2012-present, Society for Social Neuroscience 
2013-present, Georgia State University Committee for the Atlanta Science 
Festival: Discovery Day Sub-Committee  
2013-2014, Neuroscience Graduate Student Association, Co-Chair & Co-Host for 
Keynote Speaker 2013-2014 
 
|Honors & 
Awards|   
2003, American Field Service Exchange  & Scholarship  
2009, Wheel & Chain 
2009, Center for Neuromics Award for Research 
 
|Additional & 
Relevant  
Experience|   
2002-2004, Young Explorers Summer Experience: Assistant Teacher 
2011-2013, American Field Service Exchange Programs: Atlanta Area Cluster 
Support Coordinator 
